<!DOCTYPE html>

<html lang="en">
<!--[325689|cc|]--><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>Talzenna: Side effects, cost, uses, and more</title>
<meta property='og:url' content='https://www.medicalnewstoday.com/articles/325689.php'/>		<meta property="og:type" content="article"/>
		<meta property="og:site_name" content="Medical News Today"/>
		<meta property="og:title" content="Talzenna: Side effects, cost, uses, and more"/>
					<meta property="og:description" content="Talzenna (talazoparib) is a prescription drug that's used to treat certain types of breast cancer. It’s prescribed for breast cancer that’s HER2-negative, locally advanced or metastatic, and BRCA-positive. Talzenna comes as oral capsules that are taken once daily. Learn about side effects, warnings, dosage, and more."/>
			<meta name="description" content="Talzenna (talazoparib) is a prescription drug that's used to treat certain types of breast cancer. It’s prescribed for breast cancer that’s HER2-negative, locally advanced or metastatic, and BRCA-positive. Talzenna comes as oral capsules that are taken once daily. Learn about side effects, warnings, dosage, and more."/>
						<meta property="og:image" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
					<meta property="fb:admins" content="1658973110"/>
		<meta property="fb:app_id" content="147184211975697"/>
					<meta itemprop="description" content="Talzenna (talazoparib) is a prescription drug that's used to treat certain types of breast cancer. It’s prescribed for breast cancer that’s HER2-negative, locally advanced or metastatic, and BRCA-positive. Talzenna comes as oral capsules that are taken once daily. Learn about side effects, warnings, dosage, and more."/>
						<meta itemprop="image" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
					<meta name="twitter:domain" content="medicalnewstoday.com"/>
		<meta name="twitter:card" content="summary_large_image"/>
		<meta name="twitter:site" content="@mnt"/>
		<meta name="twitter:title" content="Talzenna: Side effects, cost, uses, and more"/>
					<meta name="twitter:description" content="Talzenna (talazoparib) is a prescription drug that's used to treat certain types of breast cancer. It’s prescribed for breast cancer that’s HER2-negative, locally advanced or metastatic, and BRCA-positive. Talzenna comes as oral capsules that are taken once daily. Learn about side effects, warnings, dosage, and more."/>
					<meta name="twitter:creator" content="@mnt"/>
					<meta name="twitter:image:src" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
			<META name="rating" content="general">
<META http-equiv="Cache-Control" content="no-cache">
<meta name="p:domain_verify" content="ca332f19ebf583ba72eff99cc210a982"/>
<meta name="msvalidate.01" content="65DAC77377665AE872AC660E37807BC6" />
<META http-equiv="bulletin-text" content="Copyright">

			<link rel="canonical" href="https://www.medicalnewstoday.com/articles/325689.php">
			
<link rel="shortcut icon" type="image/png" href="https://cdn-prod.medicalnewstoday.com/favicon.png">
<link rel="icon" sizes="32x32" href="https://cdn-prod.medicalnewstoday.com/favicon.ico">
<link rel="apple-touch-icon" type="image/png" href="https://cdn-prod.medicalnewstoday.com/apple-touch-icon.png">

	<link rel="alternate" type="application/rss+xml" title="Medical News Today - Health News Headlines RSS Feed" href="https://rss.medicalnewstoday.com/featurednews.xml">
	<link rel="alternate" type="application/json" title="Medical News Today - Health News Headlines JSON Feed" href="https://rss.medicalnewstoday.com/json/featurednews.json">
	
<meta http-equiv="x-dns-prefetch-control" content="on">
<link rel="preconnect dns-prefetch" href="//cdn-prod.medicalnewstoday.com" crossorigin>
<link rel="preconnect dns-prefetch" href="//cdn2.medicalnewstoday.com" crossorigin>


	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff2">
	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-Light.woff2">
	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-Regular.woff2">


	<style>
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff') format('woff');
			font-weight:900;
			font-display: swap;}
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-Light.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-Light.woff') format('woff');
			font-weight:200;
			font-style:lighter;
			font-display: swap;}
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-Regular.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-Regular.woff') format('woff');
			font-weight:400;
			font-weight:normal;
			font-style:normal;
			font-display: swap;}

		@font-face {
			font-family: 'ProximaNova';
			src: url('https://cdn-prod.medicalnewstoday.com/structure/fonts/ProximaNova/ProximaNova-Bold.woff2') format('woff2'),
			url('https://cdn-prod.medicalnewstoday.com/structure/fonts/ProximaNova/ProximaNova-Bold.woff') format('woff');
			font-weight:600;
			font-weight:bold;
			font-style:bold;
			font-display: swap;}

		@font-face {
			font-family: 'Arnhem';
			src: url('https://cdn-prod.medicalnewstoday.com/structure/fonts/Arnhem/ArnhemPro-Bold.woff') format('woff');
			font-weight:600;
			font-weight:bold;
			font-style:bold;
			font-display: swap;}
	</style>





	
<link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN" crossorigin="anonymous">

					<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_default_redesign_7721.css?v=190904" type="text/css" media="all" />
		

		



					<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_print_redesign_7721.css?v=20181203" type="text/css" media="print">
				
		


<!--[if lt IE 9]>
<script src="//html5shim.googlecode.com/svn/trunk/html5.js"></script>

			<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_ie.css" type="text/css" media="all" />
	


	<![endif]-->
<!--[if IE 7]>

<script src="//ie7-js.googlecode.com/svn/version/2.1(beta4)/IE7.js"></script>
<![endif]-->	
<!--[if IE 9]>
<script src="//ie7-js.googlecode.com/svn/version/2.1(beta4)/IE9.js"></script>
<![endif]-->


<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=0.2, maximum-scale=2.0, user-scalable=1"><!--desktop-->


<noscript>
<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/styles_noscript.css" type="text/css" media="all" />	
</noscript>
<script type="text/javascript" >
			var glob_mntcookie = 1;
	  </script>
<script>

glob_JS=(typeof glob_JS === 'undefined')?{'GAInit':[],'GA':[],"ExternalJS":[],"AD":[]}:glob_JS;

glob_TrueOnGDPR=(glob_mntcookie!=1);

//if use GDPR is true, we need this flag to make sure ga queue can ber execute after ga is ready
glob_isGaReady=!glob_TrueOnGDPR;



if(typeof fireOrSaveGoogleAdFunctions === 'undefined'){



    function fireOrSaveGoogleAdFunctions(adFunction){

        if(!glob_TrueOnGDPR){

            adFunction();

        }else{

            if(typeof fireOrSaveGoogleADs === 'undefined'){
                //save ad event in queue
                glob_JS.AD.push(adFunction);
            }else{
                //let next function to determine save or fire ad function
                fireOrSaveGoogleADs(adFunction);

            }
        }

    }

    function fireOrSaveJsFunctions(jsType,jsFunction){

        if(!glob_TrueOnGDPR && jsType!=0){
            //if GDPR already accept, and func type is not ga event, just exec

            jsFunction()

        }else if(!glob_TrueOnGDPR && jsType===0) {
            //for ga event only

            if(glob_isGaReady) {
                //if ga ready, call the function
                jsFunction();
            }else{
                //if user accept GDPR, but ga not ready, still push new command into queue
                glob_JS.GA.push(jsFunction);

            }

        }else{

                if(jsType<0){
                    jsType='GAInit'
                }else if(jsType==0){
                    jsType='GA';
                }else{
                    jsType='ExternalJS';
                }

                if(typeof fireJS === 'undefined'){
                    //save ad event in queue


                    if(jsType=='GAInit'){

                        glob_JS.GAInit.push(jsFunction);

                    }else if(jsType=='GA') {

                        glob_JS.GA.push(jsFunction);
                    }else
                    {
                        //default is other js
                        glob_JS.ExternalJS.push(jsFunction);
                    }


                }else{
                    //let next function to determine save or fire ad function
                    fireJS(jsType,jsFunction);

                }
            }
    }



    function loadScript(url, parameters,callback){



        var script = document.createElement("script");
        script.type = "text/javascript";


        //add custom attribute
        for (var key in parameters) {
            if (parameters.hasOwnProperty(key)) {
                script.setAttribute(key,parameters[key]);
            }
        }


        if (script.readyState){  //IE
            script.onreadystatechange = function(){
                if (script.readyState == "loaded" ||
                    script.readyState == "complete"){
                    script.onreadystatechange = null;
                    callback();
                }
            };
        } else {  //Others
            script.onload = function(){

                if(typeof callback === 'function'){
                    callback();
                }

            };
        }

        script.src = url;
        document.getElementsByTagName("head")[0].appendChild(script);
    }



}

</script>




<!--<script type='text/javascript'>
(function() {
var useSSL = 'https:' == document.location.protocol;
var src = (useSSL ? 'https:' : 'http:') +
'//www.googletagservices.com/tag/js/gpt.js';
document.write('<scr' + 'ipt src="' + src + '"></scr' + 'ipt>');
})();
</script>-->


<script type="text/javascript">
	//CMP	
 	var isEEA = false;
 	var passEEACheck = false;

	var metadata = 'BOSk20WOSk20WABABBENBR-AAAAeCAFAAUABwAEAANABCA';
	var purposeConsents = { 1: true, 2: true, 3: true, 4: true, 5: true };
	var vendorConsents = { 10:true, 28: true, 32: true, 52: true, 132: true };

		function __cmp(cmd, p, cb) {
			if (cmd === 'getVendorConsents' || cmd === 'getConsentData') {
				cb({
					hasGlobalScope: true,
					gdprApplies: isEEA,
					metadata: metadata,
					consentData: metadata,
					purposeConsents: purposeConsents,
					vendorConsents: vendorConsents
				}, true);
			} else if (cmd === 'ping') {
				cb({gdprAppliesGlobally: false, cmpLoaded: isEEA});
			} else {
				throw new Error('Invalid CMP command '+ cmd);
			}
		}
</script>
<!-- <script async src="//js-sec.indexww.com/ht/p/184901-208206248649346.js"></script> -->
<!-- <script async src="//js-sec.indexww.com/ht/p/180447-192872210293780.js"></script> -->
<script type="text/javascript">
	fireOrSaveJsFunctions(1,function(){
		(function() {
			var indexWrapper = document.createElement("script");
			indexWrapper.async = true;
			indexWrapper.type = "text/javascript";
			var useSSL = "https:" == document.location.protocol;
			indexWrapper.src = (useSSL ? "https:" : "http:") + "//js-sec.indexww.com/ht/p/180447-192872210293780.js";
			var node =document.getElementsByTagName("script")[0];
			node.parentNode.insertBefore(indexWrapper, node);
		})();
	});
</script>
<script type="text/javascript">
fireOrSaveJsFunctions(1,function(){
	window.headertag = window.headertag || {};
	window.headertag.pagetype='drugs';
});
</script>

<script type="text/javascript">
	//ADBRIDG MIGRATION: Load the Adbridg library directly after the GPT library. 
  var AdBridg = AdBridg || {};
  AdBridg.cmd = AdBridg.cmd || [];
  window.adbridgFallback = function() {
		console.log('ADBRIDG MIGRATION: library failed to load; falling back to GPT');
    var dq = [], l = [], ls = {}, lf = [], es;
    var rl = function(f) {return function(){var a=arguments, x=function(){f.apply(null,a)};lf.push(x);pl()}}
    var pl = function() {if(!l.length){while(lf.length){(lf.shift())()}}}
    dq.process = function() { while(dq.length) { googletag.display(dq.shift()); }}
    AdBridg.defineSlot = function(p, s, d) { return googletag.defineSlot(p, s, d).addService(googletag.pubads()); }
    AdBridg.defineOutOfPageSlot = function(p, d) { return googletag.defineOutOfPageSlot(p, d).addService(googletag.pubads()); }
    AdBridg.destroySlots = function(s) { return googletag.destroySlots(s); }
    AdBridg.display = function(d) { dq.push(d); if (es) { dq.process(); }}
    AdBridg.refresh = function(s, o) { googletag.pubads().refresh(s, o); }
    AdBridg.render = function() { }
    AdBridg.serve = function() { googletag.enableServices(); es=1; dq.process(); }
    AdBridg.sizeMapping = function() { return googletag.sizeMapping(); }
    AdBridg.useSizeMapping = function() { }
    AdBridg.lock = function(s) {if(ls[s]){ls[s]=null;return;}l.push(s);pl()}
    AdBridg.unlock = function(s) {var f=0; for(var i=0;i<l.length;++i){if(l[i]==s){l.splice(i,1);f=1}}; if(!f){ls[s]=1} pl()}
		AdBridg.cmd.push = function(f) {
			if (typeof(f)=='object') {
				var api_fallback = function(o) {
					googletag.cmd.push(function() {
						var fl;
						if (o.gpt_path) {
							var u=AdBridg.defineSlot(o.gpt_path,o.size||[],o.dom_id);
							if(o.size_map) {
								var m = googletag.sizeMapping();
								for(var oi=0;oi<o.size_map.length;oi++){m=m.addSize(o.size_map[oi].viewport, o.size_map[oi].sizes);}
								u.defineSizeMapping(m.build());
							}
							if(o.events) {
								if(o.events["gpt.defined"]){o.events["gpt.defined"](u);}
								fl = function(a,b){if(o.events[a]){googletag.pubads().addEventListener(b,function(e){if(e.slot===u){o.events[a](u,e)}})}}
								fl("gpt.rendered",'slotRenderEnded');
								fl("gpt.viewed",'impressionViewable');
								fl("gpt.visibilityChanged",'slotVisibilityChanged');
							}
						} else if (o.events) {
							fl = function(a,b){if(o.events[a]){googletag.pubads().addEventListener(b,function(e){o.events[a](a,e)})}}
							fl("gpt.render_raw",'slotRenderEnded');
							fl("gpt.viewed_raw",'impressionViewable');
						}
					});
				}
				if(f.length){for(var i=0;i<f.length;++i){api_fallback(f[i]);}}else{api_fallback(f);}
				f=function(){AdBridg.serve()}
			}
			return googletag.cmd.push(f);
		}
		while (AdBridg.cmd.length) { AdBridg.cmd.push(AdBridg.cmd.shift()); }
  };
	fireOrSaveJsFunctions(1, function() {
		(function() {
	      var adb = document.createElement("script");
	      adb.async = true;
	      adb.type = "text/javascript";
	      adb.src = '//prod.adspsp.com/adb.2418030m.min.js';
	      var node = document.getElementsByTagName('script')[0];
	      node.parentNode.insertBefore(adb, node);

	      // Return control to GPT if the AdBridg library fails to load.
	      adb.onerror = function() {
	        if (AdBridg.exists) { return; }
	        document.createElement('IMG').src = '//adspsp.com/pt/2418030/3/1/?e=0';
	        window.adbridgFallback();
	      }
	  })();
	});
</script>

<!-- Load DFP -->
<script type="text/javascript">
	var googletag = googletag || { };
	googletag.cmd = googletag.cmd || [ ];
	fireOrSaveJsFunctions(1,function(){
		(function() {
			var gads = document.createElement("script");
			gads.async = true;
			gads.type = "text/javascript";
			var useSSL = "https:" == document.location.protocol;
			gads.src = (useSSL ? "https:" : "http:") + "//www.googletagservices.com/tag/js/gpt.js";
			var node =document.getElementsByTagName("script")[0];
			node.parentNode.insertBefore(gads, node);
		})();
	});
</script>

<!--New header bidding-->
<script>
var amzn_win=window,amzn_c=5,amzn_x=0;while(amzn_x<amzn_c){amzn_win=amzn_win.parent;if(amzn_win.apstag)try{amzn_win.apstag.renderImp(document,"%%PATTERN:amzniid%%");amzn_x=amzn_c}catch(e){}amzn_x++};
</script> 

<script type="text/javascript">
	fireOrSaveGoogleAdFunctions(function() {
		AdBridg.cmd.push(function () {
			// ADBRIDG MIGRATION: this command to set AdSense is one of the few
			// GPT commands that should not be replaced with our library proxy.
			googletag.pubads().set("adsense_background_color", "FFFFFF");
		});
	});
</script>


<script type="text/javascript">
	var googleDegfaultAdVars = {"main":"'breast_cancer'","k1":"'breastcancer'","k2":"'cancer'","k3":"'health'","uniq":"'325689'","msiteID":"'talzennacdi'","msiteactive":"'True'","sponsoredPageNid":"''"};
	var googleAdSlotInfo = [];
	
	fireOrSaveGoogleAdFunctions(function(){
		AdBridg.cmd.push({
		  config: {
		    k1: googleDegfaultAdVars.k1 || "",
		    k2: googleDegfaultAdVars.k2 || ""
		  }
		});	
	});
	
</script>

<!-- End of old ads area -->
<script type='text/javascript'>
//Page level targeting setup
var adRPV = Math.floor(Math.random()*100)+1;
adRPV = adRPV.toString();

fireOrSaveGoogleAdFunctions(function(){
// ADBRIDG MIGRATION: the `cmd` function needs to run through AdBridg, but the
// setTargeting methods should stay native to GPT.
AdBridg.cmd.push(function() {
	googletag.pubads().setTargeting('rpv', adRPV);
	//We need to add a new key for 'url'
    googletag.pubads().setTargeting('url', encodeURI(location.pathname));

    //Set default targeting first
            if (typeof googleDegfaultAdVars !== "undefined") {
            for (var k in googleDegfaultAdVars) {
                if (k == "sub" || googleDegfaultAdVars[k].toString().indexOf(",") > -1) {
                    var finalOutput = googleDegfaultAdVars[k].split(',');
                    //Remove the single qoute
                    for (var i in finalOutput) {
                        if (finalOutput[i].trim().toString().indexOf("'") == 0) {
                            finalOutput[i] = finalOutput[i].trim().slice(1, -1);
                        } else {
    						finalOutput[i] = finalOutput[i].trim();
                        }
                    }
                } else {
                    if (googleDegfaultAdVars[k].toString().indexOf("'") == 0) {
                        //if it got single qoute inside, we remove it
                        var finalOutput = googleDegfaultAdVars[k].slice(1, -1);
                    } else {
                        var finalOutput = googleDegfaultAdVars[k];
                    }
                }
                googletag.pubads().setTargeting(k, finalOutput);
            }
        }
    	//googletag.pubads().enableAsyncRendering(); // enable async loading
	// Disable initial load, we will use refresh() to fetch ads.
	// Calling this function means that display() calls just
	// register the slot as ready, but do not fetch ads for it.
	// googletag.pubads().disableInitialLoad();
 //  	googletag.pubads().enableSingleRequest();
    // googletag.pubads().enableLazyLoad({
    //     fetchMarginPercent: 50,  // Fetch slots within 5 viewports.
    //     renderMarginPercent: 30,  // Render slots within 2 viewports.
    //     mobileScaling: 2.0  // Double the above values on mobile.
    // });
	// googletag.enableServices();
    // ADBRIDG MIGRATION: by default, we enable single request, disable initial
    // load, and async rendering is enabled by default (GPT no longer supports
    // synchronous rendering as of 2019-01-21.)
    // All we need to do now is tell AdBridg to begin serving the ads.
    // AdBridg.serve();
    // console.log("serve happened in page level");

});
});
</script>
<script>
// check viewport for resize events and reload ads (1000ms delay)
var resizeTimer;
var width = window.innerWidth;

function resizer() {
	//Check to see if the width is changed 
	var newWidth = window.innerWidth;
	if (width != newWidth) {
		// check if we've crossed a break point (only need to refresh if crossing the 1000px break point)
		if (width >= 1000 && newWidth < 1000) {
			
							// DECREASE IN WIDTH
				fireOrSaveGoogleAdFunctions(function() {
					AdBridg.cmd.push(function () {
						if (typeof window.DLB1 !== "undefined") {
							AdBridg.refresh([window.DLB1]);
						}
					});
				});
			
			// send resize+refresh event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / Shrink / Ad refresh', eventLabel: 'Resize / Shrink / Ad refresh'});});
			
		} else if (width < 1000 && newWidth >= 1000) {
			
			// INCREASE IN WIDTH
			// 
							if(typeof window.DLB1 !== "undefined"){
					AdBridg.refresh([window.DLB1]);	
				}
						
			// send resize+refresh event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / Grow / Ad refresh', eventLabel: 'Resize / Grow / Ad refresh'});});
			
		} else {
			// send resize event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / No ad refresh', eventLabel: 'Resize / No ad refresh'});});
		}
	}

	width = newWidth;
}

window.addEventListener("resize", function(){ 
	clearTimeout(resizeTimer);
	resizeTimer = setTimeout(resizer, 1000);
});

</script>

<!--New header bidding-->
<script>
		!function(a9,a,p,s,t,A,g){if(a[a9])return;function q(c,r){a[a9]._Q.push([c,r])}a[a9]={init:function(){q("i",arguments)},fetchBids:function(){q("f",arguments)},setDisplayBids:function(){},_Q:[]};A=p.createElement(s);A.async=!0;A.src=t;g=p.getElementsByTagName(s)[0];g.parentNode.insertBefore(A,g)}("apstag",window,document,"script","//c.amazon-adsystem.com/aax2/apstag.js");


		var initParams = {
			pubID: '3083',
			adServer: 'googletag'
		};


		fireOrSaveJsFunctions(1,function(){

			if (passEEACheck||(isEEA&&glob_mntcookie)) {
				__cmp('getConsentData', null, function(vendorConsentData, success) {
					
					initParams.gdpr = { enabled: true, consent: vendorConsentData.metadata };
					apstag.init(initParams);
				});
			} else {
				apstag.init(initParams);
			}

	 })

</script>

	


	<script type="text/javascript">
	this.top.location!==this.location&&(this.top.location=this.location);
	</script>
	<style>.async-hide { opacity: 0 !important} </style>
<script>(function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date;
h.end=i=function(){s.className=s.className.replace(RegExp(' ?'+y),'')};
(a[n]=a[n]||[]).hide=h;setTimeout(function(){i();h.end=null},c);h.timeout=c;
})(window,document.documentElement,'async-hide','dataLayer',4000,
{'GTM-W59HFNJ':true});</script>

	<script type="text/javascript">

			<!-- GA Universal Code 2014-08 (obfuscated) -->

			eval(function(p,a,c,k,e,d){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};while(c--){if(k[c]){p=p.replace(new RegExp('\\b'+e(c)+'\\b','g'),k[c])}}return p}('5(-1,2(){(2(i,s,o,g,r,a,m){i[\'c\']=r;i[r]=i[r]||2(){(i[r].q=i[r].q||[]).e(d)},i[r].l=1*j h();a=s.b(o),m=s.6(o)[0];a.7=1;a.8=g;m.9.k(a,m)})(y,A,\'z\',\'//x.n-3.t/3.u\',\'4\')});5(-1,2(){4(\'v\',\'p-w-1\',\'f\')});',37,37,'||function|analytics|ga|fireOrSaveJsFunctions|getElementsByTagName|async|src|parentNode||createElement|GoogleAnalyticsObject|arguments|push|auto||Date||new|insertBefore|||google||UA||||com|js|create|849615|www|window|script|document'.split('|')))


	</script>
		<script type="text/javascript">
	/*
	CSS Browser Selector v0.4.0 (Nov 02, 2010)
	Rafael Lima (http://rafael.adm.br)
	http://rafael.adm.br/css_browser_selector
	License: http://creativecommons.org/licenses/by/2.5/
	Contributors: http://rafael.adm.br/css_browser_selector#contributors
	*/
	function css_browser_selector(u){var ua=u.toLowerCase(),is=function(t){return ua.indexOf(t)>-1},g='gecko',w='webkit',s='safari',o='opera',m='mobile',h=document.documentElement,b=[(!(/opera|webtv/i.test(ua))&&/msie\s(\d)/.test(ua))?('ie ie'+RegExp.$1):is('firefox/2')?g+' ff2':is('firefox/3.5')?g+' ff3 ff3_5':is('firefox/3.6')?g+' ff3 ff3_6':is('firefox/3')?g+' ff3':is('gecko/')?g:is('opera')?o+(/version\/(\d+)/.test(ua)?' '+o+RegExp.$1:(/opera(\s|\/)(\d+)/.test(ua)?' '+o+RegExp.$2:'')):is('konqueror')?'konqueror':is('blackberry')?m+' blackberry':is('android')?m+' android':is('chrome')?w+' chrome':is('iron')?w+' iron':is('applewebkit/')?w+' '+s+(/version\/(\d+)/.test(ua)?' '+s+RegExp.$1:''):is('mozilla/')?g:'',is('j2me')?m+' j2me':is('iphone')?m+' iphone':is('ipod')?m+' ipod':is('ipad')?m+' ipad':is('mac')?'mac':is('darwin')?'mac':is('webtv')?'webtv':is('win')?'win'+(is('windows nt 6.0')?' vista':''):is('freebsd')?'freebsd':(is('x11')||is('linux'))?'linux':'','js']; c = b.join(' '); h.className += ' '+c; return c;}; css_browser_selector(navigator.userAgent);
	</script>
	<script type="text/javascript">
var viewportWidth = Math.max(document.documentElement.clientWidth, window.innerWidth || 0);
var viewportHeight = Math.max(document.documentElement.clientHeight, window.innerHeight || 0);

	switch (true) {
		case viewportWidth > 1360:
			var viewportBreakpoint = 'Desktop - XL';
			break;
		case viewportWidth > 1200:
			var viewportBreakpoint = 'Desktop - L';
			break;
		case viewportWidth > 1000:
			var viewportBreakpoint = 'Desktop - M';
			break;
		default:
			var viewportBreakpoint = 'Desktop - S';
	}
	
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension20', viewportBreakpoint);});

var existUserId=false;
var vanillaAjax=function(url,httpMethod,data,headerJsonString){

	var request = new XMLHttpRequest();


	request.open(httpMethod, url, true);


	//set header if exist
	try{
		var headerObj=JSON.parse(headerJsonString);

		for (var headerName in headerObj) {

			//optional check for properties from prototype chain
			if (headerObj.hasOwnProperty(headerName)) {
				//no a property from prototype chain

				var headerValue = headerObj[headerName];
				request.setRequestHeader(headerName,headerValue);

			}
		}

	}catch(e){
		console.log("Set datadog api header failed");
		//don't set header if something wrong;
	}




	request.onload = function() {

		if (request.status >= 200 && request.status < 400) {
			// Success!
			var resp = request.responseText;

		} else {
			// We reached our target server, but it returned an error

		}
	};

	request.onerror = function() {
		// There was a connection error of some sort
	};

	request.send(data);

};



function getUrlVars(targetField) {
	var vars = {};
	var parts = window.location.href.replace(/[?&]+([^=&]+)=([^&]*)/gi,
	function(m,key,value) {
		vars[key] = value;
	});

	if(typeof vars[targetField] !== "undefined"){

		return vars[targetField];

	}else{

		return "";
 	}

}


fireOrSaveJsFunctions(0,function() {ga('set', 'dimension35', getUrlVars("tc"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension36', getUrlVars("subid"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension37', getUrlVars("subid2"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension38', getUrlVars("apsid"));});


//set dimension34 value if exist

if(existUserId){

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension34', existUserId);});

}else if(getUrlVars("apid")){

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension34', getUrlVars("apid"));});

	vanillaAjax("/account/message-session-setter.php","POST","activation_platform_user_id="+getUrlVars("apid"),"{\"Content-type\":\"application/x-www-form-urlencoded\"}");

}

//will be called from newsletter register.
function setUserId(userId){

ga('set', 'dimension34', ""+userId);

}

fireOrSaveJsFunctions(0,function() {ga('set', 'dimension40', 'Zara Risoldi Cochrane, PharmD, MS, FASCP');});
		

fireOrSaveJsFunctions(0,function() {ga('set', {
'dimension1': "no",
'dimension2': "drugs_tabbed",
'dimension3': "Breast Cancer",
'dimension5': "month",
'dimension6': "desktop",
'dimension12': "2019-08-15",
'dimension17': "7721",
'dimension21': "2",
'dimension23': "Lindsay Slowiczek, PharmD",
'dimension27': "1",
'dimension28': "breastcancer",
'dimension29': "cancer"
});});

if (window.devicePixelRatio) {
	var pixelRatio = (window.devicePixelRatio >= 1.5) ? "HiDPI" : "1X";
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension7', pixelRatio);});
}

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension10', viewportWidth);});
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension11', viewportHeight);});
	
	var MNT_ga_paramKey = (document.location.search.indexOf('?') > -1 ? '&' : '?');
	var MNT_ga_url_msId_fragment = MNT_ga_paramKey + 'gaPage=[talzennacdi]';  
	var MNT_ga_url_msId = document.location.pathname + document.location.search + MNT_ga_url_msId_fragment;
	
		fireOrSaveJsFunctions(0,function() {ga('set', 'page', MNT_ga_url_msId);});
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension16', 'talzennacdi');});fireOrSaveJsFunctions(0,function() {ga('require', 'GTM-W59HFNJ');});
fireOrSaveJsFunctions(0,function() {ga('send', 'pageview');});

setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 030','325689')});",30000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 050','325689')});",50000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 070','325689')});",70000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 090','325689')});",90000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 110','325689')});",110000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 130','325689')});",130000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 150','325689')});",150000)
</script>
<script>
	fireOrSaveJsFunctions(1,function() {

		var _qevents = _qevents || [];

		(function() {
			var elem = document.createElement('script');
			//elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js";
			elem.src = "https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/quant.js";
			elem.async = true;
			elem.type = "text/javascript";
			var scpt = document.getElementsByTagName('script')[0];
			scpt.parentNode.insertBefore(elem, scpt);
		})();

		_qevents.push({
			qacct:"p-v03RmX3GES6RT"
		});
	});


</script>

<script>
	fireOrSaveJsFunctions(1,function() {

		window._comscore = window._comscore || [];
		window._comscore.push({ c1: "2", c2: "19983957" });
		(function() {
			var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true;
			//s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js";
			s.src = "https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/beacon.js";
			el.parentNode.insertBefore(s, el);
		})();

	})

</script>
<noscript>
  <img class="no_js" src="https://sb.scorecardresearch.com/p?c1=2&c2=19983957&cv=2.0&cj=1" />
</noscript>

<script>


	fireOrSaveJsFunctions(1,function() {

		!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?
			n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;
			n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
			t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
			document,'script','https://connect.facebook.net/en_US/fbevents.js');

		fbq('init', '1039134266174910');
		fbq('track', "PageView");

		fbq('track', 'ViewContent');

	});


</script>

<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=1039134266174910&ev=PageView&noscript=1"
/></noscript>

<!-- Source: /controltag?confid=qqeynsltk&site=medical%20news%20today&edit=1 -->
<script class="kxct" data-id="qqeynsltk" data-timing="async" data-version="1.9" type="text/javascript">
	fireOrSaveJsFunctions(1,function() {
		window.Krux || ((Krux = function () {
			Krux.q.push(arguments)
		}).q = []);
		(function () {
			var k = document.createElement('script');
			k.type = 'text/javascript';
			k.async = true;
			var m, src = (m = location.href.match(/\bkxsrc=([^&]+)/)) && decodeURIComponent(m[1]);
			k.src = /^https?:\/\/([a-z0-9_\-\.]+\.)?krxd\.net(:\d{1,5})?\//i.test(src) ? src : src === "disable" ? "" :
			(location.protocol === "https:" ? "https:" : "http:") + "//cdn.krxd.net/controltag?confid=qqeynsltk";
			var s = document.getElementsByTagName('script')[0];
			s.parentNode.insertBefore(k, s);
		}());
	});
</script>


<!-- Hotjar Tracking Code for https://www.medicalnewstoday.com/ -->
<script>
	(function(h,o,t,j,a,r){
		h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
		h._hjSettings={hjid:1295463,hjsv:6};
		a=o.getElementsByTagName('head')[0];
		r=o.createElement('script');r.async=1;
		r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
		a.appendChild(r);
	})(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
</script>
<script type="text/javascript"> window.jstag=function(){function t(t){return function(){return t.apply(this,arguments),this}}function n(){var n=["ready"].concat(c.call(arguments));return t(function(){n.push(c.call(arguments)),this._q.push(n)})}var i={_q:[],_c:{},ts:(new Date).getTime(),ver:"2.0.0"},c=Array.prototype.slice;return i.init=function(t){return i._c=t,t.synchronous||i.loadtagmgr(t),this},i.loadtagmgr=function(t){var n=document.createElement("script");n.type="text/javascript",n.async=!0,n.src=t.url+"/api/tag/"+t.cid+"/lio.js";var i=document.getElementsByTagName("script")[0];i.parentNode.insertBefore(n,i)},i.ready=n(),i.send=n("send"),i.mock=n("mock"),i.identify=n("identify"),i.pageView=n("pageView"),i.bind=t(function(t){i._q.push([t,c.call(arguments,1)])}),i.block=t(function(){i._c.blockload=!0}),i.unblock=t(function(){i._c.blockload=!1}),i}(),window.jstag.init({cid:"107d418c4b7bb3debf57a3af0ce16190", url:"//c.lytics.io", min:true, loadid:false}); </script>

<!-- Facebook Pixel Code -->
<script>

	fireOrSaveJsFunctions(1,function() {

		!function (f, b, e, v, n, t, s) {
			if (f.fbq)return;
			n = f.fbq = function () {
				n.callMethod ?
					n.callMethod.apply(n, arguments) : n.queue.push(arguments)
			};
			if (!f._fbq)f._fbq = n;
			n.push = n;
			n.loaded = !0;
			n.version = '2.0';
			n.queue = [];
			t = b.createElement(e);
			t.async = !0;
			t.src = v;
			s = b.getElementsByTagName(e)[0];
			s.parentNode.insertBefore(t, s)
		}(window,
			document, 'script', 'https://connect.facebook.net/en_US/fbevents.js');

		fbq('init', '1039134266174910');
		fbq('track', "PageView");
	});
</script>

<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=1039134266174910&ev=PageView&noscript=1"
/></noscript>



<!--Moat content code-->
<script>

	fireOrSaveJsFunctions(1,function(){

		(function(){function t(){for(var a=[8],e=1;2>=e;e++)a.push(8+e),a.push(8-e);a=a[Math.floor(Math.random()*a.length)];return{b:a,a:0==Math.floor(Math.random()*a)}}function k(a){var e=a=a.replace(":","");try{for(var b=0;100>b&&(a=decodeURIComponent(a),e!=a)&&!a.match(/^http(s)?\:/);b++)e=a}catch(c){}return a.replace(/(^\s+|\s+$)/g,"")}try{if(!location||!location.hostname||!location.pathname)return!1;var c=document.location.hostname.replace(/^www\./,""),u=function(){for(var a,b=document.getElementsByTagName("meta"),c,d=0,f=b.length;d<f;d++)if(c=b[d],"og:title"===c.getAttribute("property")){a=c.getAttribute("content");break}a||(a=document.title||"Untitled");return a}(),b={},b=function(a,b,c){a.l1=b;a.l2=c;a.l3="__page__";a.l4="-";return a}(b,c,u),l=(new Date).getTime(),m=Math.floor(Math.random()*Math.pow(10,12)),d,f;f=t();f.a?d=f.b:d=0;b.zmoatab_cm=d;b.t=l;b.de=m;b.zMoatAB_SNPT=!0;var g;d?g=d:g=1;var n;n=f?f.a?!0:!1:!0;var c=[],p=[k(b.l1),k(b.l2),k(b.l3),k(b.l4)].join(":"),v="https://wve3oiypgri4-a.akamaihd.net/z.gif?e=17&d="+
			encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&mp=1&ac=1&pl=1&bq=10&vc=2&cs=0",w="https://px.moatads.com/pixel.gif?e=17&d="+encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&mp=0&ac=1&pl=1&bq=10&ad_type=img&vc=2&cs=0",x="https://px.moatads.com/pixel.gif?e=17&d="+encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&ku=1&ac=1&pl=1&bq=10&ad_type=img&vc=2&cs=0";n&&((new Image).src=v,(new Image).src=w);for(var q in b)c.push(q+"="+encodeURIComponent(b[q]));
			var c=c.join("&"),c=c+"&vc=2",h=document.createElement("script");h.type="text/javascript";h.async=!0;n&&(h.onerror=function(){(new Image).src=x});var r=document.getElementsByTagName("script")[0];r.parentNode.insertBefore(h,r);h.src="https://z.moatads.com/healthlinecontent451781663455/moatcontent.js#"+c}catch(a){try{var y="//pixel.moatads.com/pixel.gif?e=24&d=data%3Adata%3Adata%3Adata&i=MOATCONTENTABSNIPPET1&vc=2&ac=1&k="+encodeURIComponent(a)+"&j="+encodeURIComponent(document.referrer)+"&cs="+(new Date).getTime();
			(new Image).src=y}catch(e){}}})();


	});

</script>
</head>
<body id="drugs" class="article v2 tabbed lang_en">
<div itemscope="" itemtype="http://schema.org/NewsArticle">








<noscript>
<div class="header_message enable_js error">
<p>For full functionality, it is necessary to enable JavaScript. Here are <a href="http://www.enable-javascript.com" rel="noopener noreferrer" target="_blank">instructions how to enable JavaScript</a> in your web browser.</p>
</div>


<div class="fullscreen_outer">
	<div class="fullscreen_inner">
		<h5>Welcome to Medical News Today</h5>
		<p>
			Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a <a href="https://www.medicalnewstoday.com/privacy-policy#vendors" target="_blank">current list</a>) using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent.</p>
		<p>
			Healthline Media, Inc. is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.
		</p>
		<p>
			By clicking “accept” below, you acknowledge and grant your consent for these activities unless and until you withdraw your consent using our <a href="https://www.healthline.com/rights-request" rel="noopener noreferrer" target="_blank">rights request form</a>. Learn more in our <a href="https://www.medicalnewstoday.com/privacy-policy" target="_blank">Privacy Policy</a>.
		</p>
	</div>
</div>


</noscript>
<div id="header_message" class="new_menu">
<input type="hidden" id="is_usermobile" name="is_usermobile" value="0">





 
</div>

<div id="navigation" class="container default_menu new_menu">

	<div class="row">

		<nav role="navigation" class="main_nav">
		
			<ul class="main_nav left"> 	
				<li class="menu_topics">
					<a href="#"></a>
		
					
<div class="menu_panel fullscreen_outer topics">
  <div class="menu_panel fullscreen_inner">
    <div class="row">
					
					
					<div class="topics">
												
							<div class="menu_topic_container">
							
								<ul class="topic_headings">
									<li class="topic_headings_top"><span>Top categories</span>
										<ul class="topic_popular_list">
											<li><a href="/categories/blood">Blood / Hematology</a></li>
<li><a href="/categories/bones">Bones / Orthopedics</a></li>
<li><a href="/categories/breast_cancer">Breast Cancer</a></li>
<li><a href="/categories/colorectal_cancer">Colorectal Cancer</a></li>
<li><a href="/categories/depression">Depression</a></li>
<li><a href="/categories/gastrointestinal">GastroIntestinal</a></li>
<li><a href="/categories/hypertension">Hypertension</a></li>
<li><a href="/categories/lymphoma">Lymphoma</a></li>
<li><a href="/categories/mens_health">Men's Health</a></li>
<li><a href="/categories/neurology">Neurology / Neuroscience</a></li>
<li><a href="/categories/nutrition-diet">Nutrition / Diet</a></li>
<li><a href="/categories/pain">Pain / Anesthetics</a></li>
<li><a href="/categories/prostate">Prostate / Prostate Cancer</a></li>
<li><a href="/categories/psoriasis">Psoriasis</a></li>
<li><a href="/categories/respiratory">Respiratory</a></li>
<li><a href="/categories/sexual_health">Sexual Health / STDs</a></li>
<li><a href="/categories/stroke">Stroke</a></li>
<li><a href="/categories/tuberculosis">Tuberculosis</a></li>
<li><a href="/categories/urology-nephrology">Urology / Nephrology</a></li>
<li><a href="/categories/womens_health">Women's Health</a></li>
										</ul> 	
									</li>
																											
									<li class="topic_headings_all"><span>All categories</span>
										<ul class="topic_all_list">
											<li><a href="/categories#a">A - B</a></li>
											<li><a href="/categories#c">C - D</a></li>
											<li><a href="/categories#e">E - G</a></li>
											<li><a href="/categories#h">H - L</a></li>
											<li><a href="/categories#m">M - O</a></li>
											<li><a href="/categories#p">P - R</a></li>
											<li><a href="/categories#s">S - Z</a></li>
											<li><a href="/categories">All Topics</a></li>
										</ul>	
									</li>


								</ul> 									
							</div> 	
						
							<div class="menu_cta_container">
							
									<span>More</span>	
																		
									<ul class="topic_more_list">
										<li class="menu_newsletter_cta"><a href="#" class="new_reg_signup menu_item_link" data-signup-source="menu_item_link"><span class="icon_container"></span>Sign up for our newsletter</a></li>
										<li class="menu_discover_cta"><a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-menu-cta-2017.png" height="15" width ="34"/>Discover in-depth, condition specific articles written by our in-house team.</a></li>

									</ul> 	
	
							</div> 	
			
			
											
					</div> 	
					</div> 	
					</div> 	
											
											
											
					</div> 	
			  
				</li> 	

					<li class="menu_newsletter">

						<a href="#" data-signup-source="menu_newsletter_link" class="menu-newsletter-link  new_reg_signup"><div>Newsletter</div></a>

					</li> 	

			</ul>
				
			<div class="logo">
				<a href="/" accesskey="h" title="Medical News Today : Home">
					<img src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-2017-640-60.png" alt="MNT home">
					<p>MNT - Hourly Medical News Since 2003</p>
				</a>
			</div> 	
				
			<ul class="main_nav right"> 	

			<div id="search_area">


<div id="searchwrapper" class="">



<div class="search_trigger">

<form id="searchFormHeader" action="/search" >
<input type="text" id="header_search" placeholder="" class="searchbox" name="q" maxlength="150" autocomplete="off"/>
<button class="screen_only black float_right" id="header_search_button" type="submit" id="" title="Search MNT" value="">Search</button>
<button class="mobile_only blue float_right" id="header_search_button" type="submit" title="Search MNT" value="">Go</button>
<input type="hidden" name="p" value="1" />
</form>



</div>
	

</div>
</div>	
			


					<li class="menu_login">
						<a href="#" id="menu_login_link">
							<div>

							</div>
						</a>
					</li>
			</ul>
		</nav>	

	</div> 	

</div> 
<div id="navigation_scroll" class="container light  ">

<div class="row">

<nav id="subnavigation">

			<ul class="main_nav left"> 	
				<li class="menu_topics">
					<a href="#"></a>
		
					
<div class="menu_panel fullscreen_outer topics">
  <div class="menu_panel fullscreen_inner">
    <div class="row">
					
					
					<div class="topics">
												
							<div class="menu_topic_container">
							
								<ul class="topic_headings">
									<li class="topic_headings_top"><span>Top categories</span>
										<ul class="topic_popular_list">
											<li><a href="/categories/blood">Blood / Hematology</a></li>
<li><a href="/categories/bones">Bones / Orthopedics</a></li>
<li><a href="/categories/breast_cancer">Breast Cancer</a></li>
<li><a href="/categories/colorectal_cancer">Colorectal Cancer</a></li>
<li><a href="/categories/depression">Depression</a></li>
<li><a href="/categories/gastrointestinal">GastroIntestinal</a></li>
<li><a href="/categories/hypertension">Hypertension</a></li>
<li><a href="/categories/lymphoma">Lymphoma</a></li>
<li><a href="/categories/mens_health">Men's Health</a></li>
<li><a href="/categories/neurology">Neurology / Neuroscience</a></li>
<li><a href="/categories/nutrition-diet">Nutrition / Diet</a></li>
<li><a href="/categories/pain">Pain / Anesthetics</a></li>
<li><a href="/categories/prostate">Prostate / Prostate Cancer</a></li>
<li><a href="/categories/psoriasis">Psoriasis</a></li>
<li><a href="/categories/respiratory">Respiratory</a></li>
<li><a href="/categories/sexual_health">Sexual Health / STDs</a></li>
<li><a href="/categories/stroke">Stroke</a></li>
<li><a href="/categories/tuberculosis">Tuberculosis</a></li>
<li><a href="/categories/urology-nephrology">Urology / Nephrology</a></li>
<li><a href="/categories/womens_health">Women's Health</a></li>
										</ul> 	
									</li>
																											
									<li class="topic_headings_all"><span>All categories</span>
										<ul class="topic_all_list">
											<li><a href="/categories#a">A - B</a></li>
											<li><a href="/categories#c">C - D</a></li>
											<li><a href="/categories#e">E - G</a></li>
											<li><a href="/categories#h">H - L</a></li>
											<li><a href="/categories#m">M - O</a></li>
											<li><a href="/categories#p">P - R</a></li>
											<li><a href="/categories#s">S - Z</a></li>
											<li><a href="/categories">All Topics</a></li>
										</ul>	
									</li>

								</ul> 									
							</div> 	
						
							<div class="menu_cta_container">
							
									<span>More</span>	
																		
									<ul class="topic_more_list">

										<li class="menu_newsletter_cta"><a href="#" class="new_reg_signup menu_item_link" data-signup-source="menu_item_link"><span class="icon_container"></span>Sign up for our newsletter</a></li>
										<li class="menu_discover_cta"><a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-menu-cta-2017.png" height="15" width ="34"/>Discover in-depth, condition specific articles written by our in-house team.</a></li>

									</ul> 	
	
							</div> 	
			
			
											
					</div> 	
					</div> 	
					</div> 	
											
											
											
					</div> 	
			  
				</li> 

					<li class="menu_newsletter">

						<a href="#" data-signup-source="menu_newsletter_link" class="menu-newsletter-link  new_reg_signup"><div>Newsletter</div></a>

					</li> 
				
			</ul>
				
			<div class="logo">
				<a href="/" accesskey="h" title="Medical News Today : Home">
					<img src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-2017-640-60.png" alt="MNT home">
					<p>MNT - Hourly Medical News Since 2003</p>
				</a>
			</div> 	
				
			<ul class="main_nav right"> 	
				
					

			<div id="search_area">


<div id="searchwrapper" class="">



<div class="search_trigger">

<form id="searchFormHeader" action="/search" >
<input type="text" id="header_search" placeholder="" class="searchbox" name="q" maxlength="150" autocomplete="off"/>
<button class="screen_only black float_right" id="header_search_button" type="submit" id="" title="Search MNT" value="">Search</button>
<button class="mobile_only blue float_right" id="header_search_button" type="submit" title="Search MNT" value="">Go</button>
<input type="hidden" name="p" value="1" />
</form>



</div>
	

</div>
</div>	
			


					<li class="menu_login">
						<a href="#" id="menu_login_link">
							<div>

							</div>
						</a>

					</li>
			</ul>
		
		</nav>	

	</div> 	

</div> <div class="modal fade" id="picModal" tabindex="-1" role="dialog" style="z-index: 1040; padding-left:0;">
	<div class="modal-dialog" role="document">
		<div class="modal-content" style="">
			<div class="modal-header">
				<button type="button" class="close" data-dismiss="modal" aria-label="Close"></button>

			</div>
			<div class="modal-body" style="text-align: center;">

				<div id="picModal-loading-animation">

					<i class="fa fa-circle-o-notch fa-spin fa-3x fa-fw"></i>
					<span class="sr-only">Loading...</span>

				</div>


				<span class="helper" style="display: inline-block;height: 100%;vertical-align: middle;"></span> <img id="origin-img" src="">

			</div>

		</div>
	</div>
</div>


<div class="modal fade site_modal modal_gdpr" tabindex="-1" role="dialog" aria-hidden="true" id="gdprModal" data-backdrop="static" data-keyboard="false">
	<div class="modal-dialog" role="document">

		<div class="modal-content">

			<div class="modal-header">
			</div>

			<div class="modal-body container" onscroll="modalScroll()">
				<div class="fullscreen_outer article_header">
					<div class="fullscreen_inner">
						<h5>Please accept our privacy terms</h5>
						<p>
							We use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. We may share your information with third-party partners for marketing purposes. To learn more and make choices about data use, visit our <a href="https://www.medicalnewstoday.com/advertising" target="_blank">Advertising Policy</a> and <a href="https://www.medicalnewstoday.com/privacy-policy" target="_blank">Privacy Policy</a>. By clicking “Accept and Continue” below, (1) you consent to these activities unless and until you withdraw your consent using our rights request form, and (2) you consent to allow your data to be transferred, processed, and stored in the United States.
						</p>
					</div>
				</div>
			</div>
			<div class="modal-footer container gradient">
				<div class="article_header">
					<button class="primary" onclick="GDPRAccept()">ACCEPT AND CONTINUE TO SITE</button>
					<button class="secondary" onclick="confirmDeny()">Deny permission</button>
				</div>
			</div>

		</div>
		<div class="scroll_more hidden">
			<button class="primary" onclick="scrollAccept()">Scroll to Accept</button>
		</div>

	</div>
</div>



	<!--for new newsletter sign up proc-->
	<div class="modal fade registration_modal_form" tabindex="-1" role="dialog" aria-hidden="true" id="registrationModal">
		<div class="modal-dialog" role="document">
			<div class="modal-content modal_reg" id="registration_modal_form">
									<div class="modal-header screen_only">
						<h4 class="modal-title">Get the MNT newsletter</h4>
						<button type="button" class="close" data-dismiss="modal"></button>
					</div>
				


				<div class="modal-body" id="registration_start">

					<div class="iframe_scroll_container">

						<!--form migration start-->

						<form id="new-reg-form">
							<div class="form container_reg">
								<div class="form header_reg">

									<div class="form-group">
										<input type="email" name="formEmail" style="margin-bottom: 20px;" class="form-control newsletterFormEmail" id="inputEmail" placeholder="Enter email address" value="">
									</div>

									<!--error meesage place holder-->
									<div id="signFinishErrorHolder" class="errorHolder"></div>


									<div id="registration_modal_message" class="form-group">


										<!--while user finish the register process, something info need to tell user, but not error message-->
										<div id="newsletterRegisterInfo" class="message start">

										</div>


										<!--User will see the message everytime open the register modal-->
										<div id="newsletterTypeMessage" class="message start">

											<p>
												Enter your email address to subscribe to <span id="selectedCategoryText">our most top categories</span>
											</p>

											

<p>Your <a href="/privacy-policy" title="Privacy policy">privacy</a> is important to us.</p>

										</div>

									</div>

								</div>
							</div>

							<!--set by js-->
							<input type="hidden" id="newsletterCategories" name="newsletterCategories" value="">
							<input type="hidden" id="newsletterTypeMessageHTMLBackup" name="newsletterTypeMessageHTMLBackup" value="">

						</form>

						<!--form migration end-->

					</div>
				</div>


				<div class="modal-footer">
					<button type="button" id="email-start-signup-btn" class="btn btn-success btn-block">CONTINUE</button>

<!--					<button type="button" id="email-finish-signup-btn" class="btn btn-danger btn-block" data-dismiss="modal">OK</button>-->
				</div>				

			</div>



		</div><!-- /.modal-dialog -->
	</div><!-- /.modal -->



<div class="modal fade email-an-article-modal" tabindex="-1" role="dialog" aria-hidden="true" id="email-an-article-modal">
	<div class="modal-dialog" role="document">
		<div class="modal-content">
			<div class="modal-header">
				<h3 class="">Email an article</h3>
				<button type="button" class="close" data-dismiss="modal"></button>
			</div>
			<div class="modal-body">
				<p>You have chosen to share the following article:</p>
				<p><b id="email-an-article-title">How elderberries can help you fight the flu</b></p>
				<p>To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.<br>
					<b>Note:</b> Please don't include any URLs in your comments, as they will be removed upon submission.</p>
				<p>We do not store details you enter into this form. Please see our <a href="/privacy-policy" title="Read our Privacy Policy" target="_blank">privacy policy</a> for more information.</p>

				<form id="email-an-article-form">
					<fieldset class="form-container">
						<div>
							<label><em>*</em>Your Name (max. 30 chars)</label>
							<input id="fromName" type="text" name="fromName" maxlength="30" value="" required>
							<label for="fromName" generated="true" class="formError" style="display: none">The field 'Your Name' is required.</label>
						</div>
						<div>
							<label><em>*</em>Email Address</label>
							<input id="fromEmailAddress" class="formEmail" type="email" name="fromEmailAddress" maxlength="100" value="" required>
							<label for="fromEmailAddress" generated="true" class="formError" style="display: none">This is not a valid email address.</label>
						</div>
						<div>
							<label><em>*</em>Friend's Name (max. 30 chars)</label>
							<input id="toName" type="text" name="toName" maxlength="30" value="" required>
							<label for="toName" generated="true" class="formError" style="display: none">The field 'Friend's Name' is required.</label>
						</div>
						<div>
							<label><em>*</em>Friend's Email Address</label>
							<input id="toEmailAddress" type="email" name="toEmailAddress" maxlength="100" value="" required>
							<label for="toEmailAddress" generated="true" class="formError" style="display: none">The field 'Friend's Email Address' is required.</label>
						</div>

					</fieldset>


					<div id="email-an-article-reCAPTCHA" class="g-recaptcha" data-sitekey="6Le68KEUAAAAAOKVyWLvP5U0Dl2HT9dqR0J1hx7z"></div>




					<div class="buttonrow">
						<button type="submit" id="email_submit" class="btn-form form-submit secure">Send securely</button>
						<span class="form_secure_icon"></span>
					</div>

				</form>

				<div class="robots-nocontent">
					<div id="email-an-article-success" class="information"  style="display: none">
						<h2 class="message_box">Message sent successfully</h2>
						<p><b>The details of this article have been emailed on your behalf.</b></p>
						<p><a href="/" title="Click here to return to the MNT homepage">Click here</a> to return to the Medical News Today home page.</p>
					</div>
				</div>
			</div>
		</div>
	</div><!-- /.modal-dialog -->
</div>










<hr class="css_h1ksn" >






<div class="container"> 

<div class="row site_header"> 

<article  >

			<div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 article_header"> 		<!-- Leaderboard BANNER advert -->

<div id="dlb1_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb1_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB1',
			"slotContainer":'dlb1_container'		});
	</script>
	</div>
	<span class='bt-uid-tg' data-uid='5b84646203-160' style='display: none !important' data-style='width: 728px;height: 90px;background: rgba(255, 255, 255, 0.5);border: 2px solid #888;box-sizing: border-box;margin: 0 auto 0;'></span>

</div>






<!-- /header_ad code -->
<h1 itemprop="headline">Talzenna (talazoparib)</h1>

</div> 	<div class="col-xs-12 col-sm-12 col-md-8 col-lg-8 main_content"> 	<div id="article_date">
			<span class="date_reviewed screen_only">Last reviewed		<time itemprop="lastReviewed" datetime="2019-06-23">
		Sun 23 June 2019		</time></span>
		
		<span class="date_reviewed mobile_only">Last reviewed		Sun 23 Jun 2019</span>
		
			</div>
		<div class="author_top">
	<span class='author_byline'>By Lindsay Slowiczek, PharmD</span>	</div>
				<div class="reviewer_top">
			<span class='reviewer_byline'>Reviewed by <a href='/reviewers' class='article_author' rel='author' title='MNT medical review team' >Zara Risoldi Cochrane, PharmD, MS, FASCP</a></span>			</div>
			<span class="clearfix"></span>

<div class="article_body">
	<div itemprop="articleBody">
	<div class="article_toc collapsed article_collapsed">
<a class="collapsed__click" href="#"><i class="collapsed__icon"></i>Table of contents</a><ol class="collapsed__tabs hide">
<li><a href="#generic">Generic</a></li>
















<li><a href="#side-effects">Side effects</a></li>
















<li><a href="#cost">Cost</a></li>
















<li><a href="#talzenna-for-breast-cancer">Talzenna for breast cancer</a></li>
















<li><a href="#other-uses-studied">Other uses studied</a></li>
















<li><a href="#dosage">Dosage</a></li>
















<li><a href="#talzenna-and-alcohol">Talzenna and alcohol</a></li>
















<li><a href="#interactions">Interactions</a></li>
















<li><a href="#alternatives">Alternatives</a></li>
















<li><a href="#talzenna-vs-lynparza">Talzenna vs. Lynparza</a></li>
















<li><a href="#how-to-take">How to take</a></li>
















<li><a href="#how-it-works">How it works</a></li>
















<li><a href="#pregnancy">Pregnancy</a></li>
















<li><a href="#birth-control-needs">Birth control needs</a></li>
















<li><a href="#breastfeeding">Breastfeeding</a></li>
















<li><a href="#faqs">FAQs</a></li>
















<li><a href="#warnings">Warnings</a></li>
















<li><a href="#overdose">Overdose</a></li>
















<li><a href="#expiration">Expiration</a></li>
















<li><a href="#for-professionals">For professionals</a></li>
















</ol>
</div>
















<h2>What is Talzenna?</h2>
















<p>Talzenna is a brand-name prescription medication that's used to treat certain types of <a href="/articles/37136.php" title="What to know about breast cancer" class="keywords">breast cancer</a> in adults.</p>
















<p>It's used to treat breast cancer with each of the following characteristics:</p>
















<ul>
<li>
<strong>Hormone receptor-positive or hormone receptor-negative</strong>. These <a href="/info/cancer-oncology/" title="What is Cancer?" class="keywords">cancer</a> cells may or may not have receptors (attachment sites) for <a href="/articles/277177.php" title="Everything you need to know about estrogen" class="keywords">estrogen</a> or <a href="/articles/277737.php" title="Progesterone and progestin: How do they work?" class="keywords">progesterone</a>.</li>
















<li>
<strong>Mutations in BRCA1 or BRCA2 genes (types of breast cancer genes)</strong>. These mutations (abnormal changes) increase the risk of having certain types of cancer. Cancer with BRCA gene mutations is called BRCA-positive.</li>
















<li>
<strong>HER2-negative breast cancer</strong>. These cancer cells don't have HER2 (human epidermal growth factor receptor 2) proteins on their surface.</li>
















<li>
<strong>Advanced disease</strong>. This type of cancer has spread near your breast (called locally advanced disease) or to other parts of your body (called metastatic disease).</li>
















</ul>
<p>Talzenna comes as capsules that are taken by mouth once daily. It's available in two strengths: 1 mg and 0.25 mg.</p>
















<p>Talzenna contains the drug talazoparib, which belongs to a class of drugs called poly ADP-ribose polymerase (PARP) inhibitors. It's considered a targeted therapy because it attacks specific parts of cancer cells. It works differently than <a href="/articles/158401.php" title="What you need to know about chemotherapy" class="keywords">chemotherapy</a> (standard drugs used to treat cancer), which can affect all rapidly growing cells in your body.</p>
















<h3>Effectiveness</h3>
















<p>One <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1802905" target="_blank" rel="noopener">clinical study</a> looked at people with BRCA-positive, HER2-negative breast cancer. People taking Talzenna had longer times without their cancer growing or spreading than people who were using chemotherapy drugs.</p>
















<p>In this study, 62.6% of the people taking Talzenna had their cancer reduced by 30% or more. In people taking chemotherapy drugs, 27.2% had their cancer reduced by 30% or more.</p>
















<h3>FDA approval</h3>
















<p>Talzenna was approved by the Food and Drug Administration (FDA) in October 2018. It was the second PARP inhibitor to be approved by the FDA. The first FDA-approved drug in this class is called Lynparza (olaparib). It was approved to treat breast cancer in January 2018.</p>
















<span class="anchor" id="generic"></span>
<h2>Talzenna generic</h2>
















<p>Talzenna is available only as a brand-name medication. It's not currently available in generic form.</p>
















<p>Talzenna contains the drug talazoparib.</p>
















<span class="anchor" id="side-effects"></span>
<h2>Talzenna side effects</h2>
















<p>Talzenna can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Talzenna. These lists do not include all possible side effects.</p>
















<p>For more information on the possible side effects of Talzenna, or tips on how to deal with a troubling side effect, talk with your doctor or pharmacist.</p>
















<p>More common side effects</p>
















<p>The more common side effects of Talzenna can include:</p>
















<ul>
<li><a href="/articles/158634.php" title="What you should know about diarrhea" class="keywords">diarrhea</a></li>
















<li><a href="/articles/73936.php" title="What is causing this headache?" class="keywords">headache</a></li>
















<li><a href="/articles/70956.php" title="What's to know about alopecia areata?" class="keywords">hair loss</a></li>
















<li>nausea</li>
















<li>vomiting</li>
















<li><a href="/articles/248002.php" title="Fatigue: Why am I so tired and what can I do about it?" class="keywords">tiredness</a></li>
















<li>feeling weak</li>
















<li>loss of appetite</li>
















</ul>
<p>Most of these side effects may go away within a few days or a couple of weeks. If they're more severe or don't go away, talk to your doctor or pharmacist.</p>
















<h3>Serious side effects</h3>
















<p>Serious side effects from Talzenna can occur. Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>
















<p>Serious side effects, which are described below in "Side effect details," can include the following:</p>
















<ul>
<li>
<a href="/articles/158800.php" title="Everything you need to know about anemia" class="keywords">anemia</a> (low levels of red blood cells)</li>
















<li>neutropenia (low levels of certain white blood cells)</li>
















<li>thrombocytopenia (low levels of platelets)</li>
















<li>myelodysplastic syndrome or <a href="/articles/215538.php" title="Acute myeloid leukemia: What you need to know" class="keywords">acute myeloid leukemia</a> (cancer in your blood or <a href="/articles/285666.php" title="All you need to know about bone marrow" class="keywords">bone marrow</a>)</li>
















<li>severe allergic reaction</li>
















</ul>
<h3>Side effect details</h3>
















<p>You may wonder how often certain side effects occur with this drug. Here's some detail on several of the side effects this drug may cause.</p>
















<p><strong>Allergic reaction</strong></p>
















<p>As with most drugs, some people can have an allergic reaction after taking Talzenna. It's not known for sure how often people taking Talzenna have an allergic reaction. Symptoms of a mild allergic reaction can include:</p>
















<ul>
<li>skin rash</li>
















<li>itchiness</li>
















<li>flushing (warmth and redness in your skin)</li>
















</ul>
<p>A more severe allergic reaction is rare but possible. Symptoms of a severe allergic reaction can include:</p>
















<ul>
<li>swelling under your skin, typically in your eyelids, lips, hands, or feet</li>
















<li>swelling of your tongue, mouth, or throat</li>
















<li>trouble breathing</li>
















</ul>
<p>Call your doctor right away if you have a severe allergic reaction to Talzenna. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>
















<p><strong>Hair loss</strong></p>
















<p>Hair loss (called alopecia) was a commonly reported side effect during clinical studies. In one <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a" target="_blank" rel="noopener">study</a>, 25% of people who took Talzenna had hair loss.</p>
















<p>Most of these people lost less than 50% of their hair. In these people, the hair loss wasn't noticeable from a distance. It could only be seen up close. A small percentage of people lost larger amounts of hair. These people may have needed to wear a wig or hairpiece to disguise their hair loss.</p>
















<p>In this same study, 28% of the people using chemotherapy (standard drugs used to treat cancer) had hair loss.</p>
















<p>Hair loss caused by cancer treatments is usually temporary. Most of the time, hair grows back after treatment is finished. If you're concerned about hair loss, talk with your doctor about ways to reduce this side effect. They may recommend that you use scalp cooling caps or try other ways to improve the health of your scalp and hair.</p>
















<p><strong>Anemia</strong></p>
















<p>Anemia was a common side effect seen in people taking Talzenna during clinical studies. With anemia, your body has low levels of red blood cells.</p>
















<p>In one <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a" target="_blank" rel="noopener">study</a>, 53% of people taking Talzenna had anemia. About 18% of people using chemotherapy (standard drugs used to treat cancer) had anemia. In 39% of people taking Talzenna, anemia was considered severe enough to possibly need treatment with a blood transfusion. Less than 1% of people taking Talzenna stopped the drug because of anemia.</p>
















<p>Anemia is usually a temporary side effect of cancer treatments such as Talzenna and similar drugs. It typically improves once treatment is finished. However, it can cause symptoms that affect your quality of life.</p>
















<p>Symptoms of anemia include:</p>
















<ul>
<li>fatigue (lack of energy)</li>
















<li>feeling weak</li>
















<li><a href="/articles/150322.php" title="What to know about constipation" class="keywords">constipation</a></li>
















<li>trouble breathing</li>
















<li>bleeding from your nose or gums</li>
















<li>pale-colored skin</li>
















<li>feeling cold</li>
















<li>trouble concentrating</li>
















<li>dizziness</li>
















<li>headache</li>
















</ul>
<p>Your doctor will check you for anemia. They'll do this by ordering red blood cell counts before you start Talzenna and every month while you're taking the drug.</p>
















<p>If your red blood cell count becomes too low, your doctor may adjust your treatment. They may lower your dose of Talzenna or temporarily stop Talzenna treatment until your blood cell levels improve.</p>
















<p>If you have symptoms of anemia while using Talzenna, talk with your doctor. They can recommend ways to minimize your symptoms during treatment.</p>
















<p><strong>Neutropenia</strong></p>
















<p>Neutropenia was a common side effect seen in people taking Talzenna during studies. With neutropenia, your body has very low levels of neutrophils (a type of white blood cell that fights infections).</p>
















<p>In a <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a" target="_blank" rel="noopener">clinical study</a>, 35% of people taking Talzenna had neutropenia. About 43% of people using chemotherapy (standard drugs used to treat cancer) had neutropenia. This condition was the main reason that 0.3% of people taking Talzenna stopped treatment with the drug.</p>
















<p>If you have low levels neutrophils, you have an increased risk of infection. A <a href="/articles/168266.php" title="Fever: What you need to know" class="keywords">fever</a> is often the first symptom of neutropenia. This may be followed by infections such as respiratory infections or skin infections.</p>
















<p>Your doctor will check your neutrophil levels before you start taking Talzenna, and then monthly while you're using the drug. If your neutrophil levels are too low, your doctor may adjust your treatment. They may have you wait to start the drug, reduce your current dose of Talzenna, or temporarily stop your treatment, until your blood counts return to a safe level.</p>
















<p>If you have symptoms of neutropenia (such as a fever) while taking Talzenna, let your doctor know right away. You may need treatment if you have an infection.</p>
















<p><strong>Thrombocytopenia</strong></p>
















<p>Thrombocytopenia is another common side effect of Talzenna. With thrombocytopenia, your body has low platelet levels in your blood. Platelets help you form clots when you're bleeding. If you have low levels of platelets, you're at an increased risk of having a serious bleed.</p>
















<p>Less serious symptoms of low platelet levels include:</p>
















<ul>
<li>frequent bruising</li>
















<li>easily bleeding (often from your gums; blood may also appear in your stool)</li>
















<li>bleeding from wounds that lasts longer than normal or doesn't stop on its own</li>
















<li>nosebleeds</li>
















</ul>
<p>In a <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a" target="_blank" rel="noopener">clinical study</a>, 27% of people taking Talzenna had thrombocytopenia. Only 7% of people using chemotherapy (standard drugs used to treat cancer) had anemia. Thrombocytopenia was the main reason that 0.3% of people taking Talzenna stopped treatment with the drug.</p>
















<p>Your doctor will check your platelet count before you start treatment, and every month while you're taking Talzenna. If your platelet levels are too low, your doctor may adjust your treatment until your platelet counts return to a safe level. They may delay your next dose of Talzenna, reduce your current dose of Talzenna, or temporarily stop your treatment.</p>
















<p><strong>Myelodysplastic syndrome/Acute myeloid leukemia</strong></p>
















<p>Myelodysplastic syndrome (MDS) is a form of cancer in your blood and bone marrow. MDS can progress into acute myeloid leukemia (AML). In MDS and AML, your bone marrow produces abnormal blood cells that don't work the right way.</p>
















<p>These conditions occurred in 2 of the 584 people who received Talzenna during <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a" target="_blank" rel="noopener">clinical studies</a>. Both of these people had received chemotherapy drugs before they took Talzenna. Chemotherapy drugs may have played a role in the development of this cancer.</p>
















<p>Cancer in your blood and bone marrow can cause you to have low levels of different types of blood cells. This can lead to symptoms such as:</p>
















<ul>
<li>frequent bruising</li>
















<li>easily bleeding (from nose and gums; may also have blood in stool)</li>
















<li>trouble breathing</li>
















<li>weight loss</li>
















<li>fatigue (lack of energy)</li>
















<li>weakness</li>
















<li>frequent infections</li>
















<li>fever</li>
















<li>pain in your bones</li>
















</ul>
<p>Your doctor will test your blood levels of red blood cells, white blood cells, and platelets before you start taking Talzenna and during your treatment. Low levels of any of these could be a sign of blood or bone marrow cancer.</p>
















<div id="onequarter-of-article"></div>
<p>If you have low blood cell counts before starting Talzenna, you may need to wait to start treatment until your blood counts improve to safe levels. Some people may need to see a doctor who specializes in blood disorders before starting Talzenna.</p>
















<p>If your blood levels become too low while you're taking Talzenna, your doctor may adjust your treatment. They may delay your next dose of Talzenna, reduce your current dose of Talzenna, or temporarily stop your treatment, until your platelet counts return to a safe level.</p>
















<p>If you have symptoms of blood/bone marrow cancer while taking Talzenna, let your doctor know right away.</p>
















<span class="anchor" id="cost"></span>
<!--[MMR]--><!--[END MMR]--><h2>Talzenna cost</h2>
















<p>As with all medications, the cost of Talzenna can vary. To find current prices for Talzenna in your area, check out <a href="http://www.wellrx.com/" target="_blank" rel="noopener">WellRx.com</a>.</p>
















<p>The cost you find on WellRx.com is what you may pay without insurance. The actual price you'll pay depends on your insurance coverage and the pharmacy you use.</p>
















<h3>Financial and insurance assistance</h3>
















<p>If you need financial support to pay for Talzenna, or if you need help understanding your insurance coverage, help is available.</p>
















<p>Pfizer Oncology, the manufacturer of Talzenna, offers a program called Pfizer Oncology Together. For more information and to find out if you're eligible for support, call 877-744-5675 or visit the <a href="https://www.talzenna.com/financial-assistance" target="_blank" rel="noopener">program website</a>.</p>
















<span class="anchor" id="talzenna-for-breast-cancer"></span>
<h2>Talzenna for breast cancer</h2>
















<p>The Food and Drug Administration (FDA) approves prescription drugs such as Talzenna to treat certain conditions. Talzenna may also be used off-label for other conditions. Off-label use is when a drug that's approved to treat one condition is used to treat a different condition.</p>
















<p>Talzenna is FDA-approved to treat certain types of breast cancer in adult males and females.</p>
















<h3>About breast cancer</h3>
















<p>Breast cancer types are determined by testing cancer cells for certain receptors (attachment sites). Receptors are found on the surface of cancer cells. Different people can have different types of receptors on their cells. The following receptors may be found on breast cancer cells:</p>
















<ul>
<li>estrogen receptors (a type of hormone receptor)</li>
















<li>progesterone receptors (a type of hormone receptor)</li>
















<li>HER2 (human epidermal growth factor receptor 2) receptors</li>
















</ul>
<p>If your cancer cells have a large number of any of these receptors, your cancer is considered "positive" for that receptor. For example, if your cancer cells have a lot of HER2 receptors, the cancer is called "HER2-positive."</p>
















<p>If your cancer cells have a low number of receptors, your cancer is considered "negative" for that receptor. For example, if your cancer cells have very few HER2 receptors, the cancer is called "HER2-negative."</p>
















<p>Your doctor uses information about receptors to know more about the specific type of breast cancer you have. This helps them choose the best treatment for you.</p>
















<p>The type of treatment you receive may also depend on your genetics. People with mutations in their Breast Cancer gene 1 (BRCA1) or Breast Cancer gene 2 (BRCA2) genes have an increased risk of breast cancer. Everyone has BRCA genes, but in some people, these genes are mutated. Abnormal genes are passed down in families.</p>
















<p>Your doctor may order a test to check for BRCA mutations. This will help them personalize your cancer treatment.</p>
















<p>Sometimes breast cancer spreads outside of the breast. It may spread near your breast (locally advanced cancer) or to other parts of your body (metastatic cancer). Your doctor will order imaging tests to see where cancer has spread in your body. This also helps your doctor choose the best treatment option for you.</p>
















<h3>Talzenna treatment for breast cancer</h3>
















<p>Talzenna is used to treat breast cancer with each of the following characteristics (some of which are described in more detail in the section above):</p>
















<ul>
<li>
<strong>Hormone receptor-positive or hormone receptor-negative</strong>. These cancer cells may or may not have receptors (attachment sites) for estrogen or progesterone.</li>
















<li>
<strong>Mutations in BRCA1 or BRCA2 genes (types of breast cancer genes)</strong>. These mutations (abnormal changes) increase the risk of having certain types of cancer. Cancer with BRCA gene mutations is called BRCA-positive.</li>
















<li>
<strong>HER2-negative breast cancer</strong>. These cancer cells don't have many HER2 (human epidermal growth factor receptor 2) proteins on their surface.</li>
















<li>
<strong>Advanced disease</strong>. This type of cancer has spread near your breast (called locally advanced disease) or to other parts of your body (called metastatic disease).</li>
















</ul>
<h3>Effectiveness</h3>
















<p>One clinical study looked at people with BRCA-positive, HER2-negative breast cancer. People taking Talzenna had longer times without their cancer growing or spreading than people had who were using chemotherapy drugs.</p>
















<p>In this study, 62.6% of the people taking Talzenna had their cancer reduced by 30% or more. In people taking chemotherapy drugs, 27.2% had their cancer reduced by 30% or more.</p>
















<span class="anchor" id="other-uses-studied"></span>
<!--[DLB]--><!-- Leaderboard BANNER advert -->

<div id="dlb2_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb2_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB2',
			"slotContainer":'dlb2_container'		});
	</script>
	</div>
	<span class='bt-uid-tg' data-uid='5b846471dd-160' style='display: none !important' ></span>

</div>






<!-- /header_ad code --><!--[END DLB]--><h2>Other uses being studied</h2>
















<p>Talzenna is being studied in phase III clinical trials as a treatment for conditions other than breast cancer. Phase III trials are done to compare a new treatment to other drugs already used to treat a certain condition. Some of these phase III trials are described below.</p>
















<h3>Prostate cancer</h3>
















<p>Talzenna is being <a href="https://clinicaltrials.gov/ct2/show/NCT03395197?term=talazoparib&amp;rank=13" target="_blank" rel="noopener">studied</a> as a treatment for advanced <a href="/articles/150086.php" title="Prostate cancer in detail" class="keywords">prostate cancer</a>. In this study, Talzenna is being tested in combination with Xtandi (enzalutamide), which is a hormone-lowering drug approved to treat prostate cancer.</p>
















<h3>Ovarian cancer</h3>
















<p>Talzenna is also being <a href="https://clinicaltrials.gov/ct2/show/NCT03642132?term=talazoparib&amp;rank=27" target="_blank" rel="noopener">studied</a> as a treatment for <a href="/articles/159675.php" title="How do you get ovarian cancer?" class="keywords">ovarian cancer</a>. In this study, Talzenna is being used in combination with other anticancer drugs or following treatment with anticancer drugs. This study isn't accepting new participants any longer.</p>
















<h3>Lung cancer</h3>
















<p>An ongoing <a href="https://clinicaltrials.gov/ct2/show/record/NCT02154490" target="_blank" rel="noopener">study</a> is testing the effectiveness of Talzenna to treat advanced <a href="/info/lung-cancer/" title="What is Lung Cancer?" class="keywords">lung cancer</a>. In this study, Talzenna is being compared to several other chemotherapy and anticancer drugs.</p>
















<span class="anchor" id="dosage"></span>
<h2>Talzenna dosage</h2>
















<p>The Talzenna dosage your doctor prescribes will depend on several factors. These include:</p>
















<ul>
<li>how well your body tolerates Talzenna's side effects (such as low red blood cell or white blood cell counts)</li>
















<li>your kidney function</li>
















<li>other drugs you are taking that may interact with Talzenna</li>
















</ul>
<p>The following information describes dosages that are commonly used or recommended. <strong>However, be sure to take the dosage your doctor prescribes for you</strong>. Your doctor will determine the best dosage to suit your needs.</p>
















<h3>Drug forms and strengths</h3>
















<p>Talzenna comes as capsules that are taken by mouth. It's available in two strengths: 0.25 mg and 1 mg.</p>
















<h3>Dosage for breast cancer</h3>
















<p>The usual recommended dosage of Talzenna is 1 mg, taken by mouth once daily.</p>
















<p>The dosage of Talzenna for breast cancer treatment can be changed if needed. Your doctor may give you a lower dosage depending on several factors, such as side effects you may have and whether you have kidney disease.</p>
















<p>If you have questions about the dosage that's right for you, talk with your doctor.</p>
















<h3>What if I miss a dose?</h3>
















<p>If you miss a dose of Talzenna, just take your next dose at the regular time. Don't take more than one dose at a time. This can increase your risk of serious side effects.</p>
















<h3>Will I need to use this drug long term?</h3>
















<p>It depends on how your body responds to Talzenna. If Talzenna is preventing your cancer from growing or spreading, and you're able to manage its side effects, your doctor may recommend that you use this drug long term (several months to several years).</p>
















<span class="anchor" id="talzenna-and-alcohol"></span>
<!--[MMR]--><!--[END MMR]--><h2>Talzenna and alcohol</h2>
















<p>There aren't any known interactions between Talzenna and alcohol at this time. However, Talzenna does cause some of the same side effects that can occur after drinking too much alcohol. These side effects include:</p>
















<ul>
<li>headache</li>
















<li>diarrhea</li>
















<li>nausea</li>
















<li>vomiting</li>
















<li>fatigue (lack of energy)</li>
















</ul>
<p>Drinking alcohol while taking Talzenna may increase your risk of these side effects. Talk with your doctor about whether drinking alcohol is safe for you during your treatment with Talzenna.</p>
















<span class="anchor" id="interactions"></span>
<h2>Talzenna interactions</h2>
















<p>Talzenna can interact with several other medications. It can also interact with certain supplements as well as certain foods.</p>
















<p>Different interactions can cause different effects. For instance, some can interfere with how well a drug works, while others can cause increased side effects.</p>
















<h3>Talzenna and other medications</h3>
















<p>Below are lists of medications that can interact with Talzenna. These lists do not contain all the drugs that may interact with Talzenna.</p>
















<p>Before taking Talzenna, be sure to tell your doctor and pharmacist about all prescription, over-the-counter, and other drugs you take. Also tell them about any <a href="/articles/195878.php" title="Vitamins: What are they and what do they do?" class="keywords">vitamins</a>, herbs, and supplements you use. Sharing this information can help you avoid potential interactions.</p>
















<p>If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.</p>
















<p><strong>Certain blood pressure or heart rate medications</strong></p>
















<p>Taking Talzenna with certain <a href="/articles/270644.php" title="What is a normal blood pressure?" class="keywords">blood pressure</a> or heart rate medications can increase Talzenna levels in your body. This can increase your risk of serious side effects.</p>
















<div id="middle-of-article"></div>
<p>Examples of blood pressure or heart rate medications that can increase Talzenna levels include:</p>
















<ul>
<li>amiodarone (Nexterone, Pacerone)</li>
















<li>carvedilol (Coreg, Coreg CR)</li>
















<li>verapamil (Calan, Verelan)</li>
















<li>diltiazem (Cardizem, Cartia XR, Diltzac)</li>
















<li>felodipine</li>
















</ul>
<p>If you need to take these medications during your Talzenna treatment, your doctor will lower your Talzenna dose until you're no longer at risk for this interaction.</p>
















<p><strong>Certain anti-infectives</strong></p>
















<p>Taking Talzenna with certain <a href="/articles/10278.php" title="What to know about antibiotics" class="keywords">antibiotics</a> or antifungals can increase the levels of Talzenna in your body. This can increase your risk of serious side effects.</p>
















<p>Examples of these anti-infectives include:</p>
















<ul>
<li>azithromycin (Zithromax)</li>
















<li>clarithromycin (Biaxan XL)</li>
















<li>itraconazole (Onmel, Sporanox, Tolsura)</li>
















<li>ketoconazole (Extina, Nizoral, Xolegel)</li>
















</ul>
<p>If you need to take one of these antibiotics or antifungals while you're taking Talzenna, your doctor may lower your Talzenna dose until you're no longer taking the antibiotic or antifungal.</p>
















<span class="anchor" id="alternatives"></span>
<h2>Alternatives to Talzenna</h2>
















<p>Other drugs are available that can treat breast cancer. Some may be better suited for you than others. If you're interested in finding an alternative to Talzenna, talk to your doctor to learn more about other medications that may work well for you.</p>
















<p>Note: Some of the drugs listed here are used off-label to treat this specific condition. Off-label use is when a drug that's approved to treat one condition is used to treat a different condition.</p>
















<p>Talzenna is used to treat breast cancer that's HER2-negative and locally advanced or metastatic in people with mutated BRCA genes. Examples of other drugs that may be used to treat this type of breast cancer include:</p>
















<ul>
<li>doxorubicin (Doxil, Lipodox)</li>
















<li>paclitaxel (Abraxane, Taxol)</li>
















<li>gemcitabine (Gemzar, Infugem)</li>
















<li>capecitabine (Xeloda)</li>
















<li>vinorelbine (Navelbine)</li>
















<li>bevacizumab (Avastin, Mvasi)</li>
















<li>eribulin (Halaven)</li>
















<li>carboplatin</li>
















<li>cyclophosphamide</li>
















<li>docetaxel (Taxotere)</li>
















</ul>
<span class="anchor" id="talzenna-vs-lynparza"></span>
<h2>Talzenna vs. Lynparza</h2>
















<p>You may wonder how Talzenna compares to other medications that are prescribed for similar uses. Here we look at how Talzenna and Lynparza are alike and different.</p>
















<h3>General</h3>
















<p>Talzenna contains the drug talazoparib. Lynparza contains the drug olaparib. Both medications belong to the same class of drugs: poly ADP-ribose polymerase (PARP) inhibitors.</p>
















<h3>Uses</h3>
















<p>Talzenna and Lynparza are both FDA-approved for use in adults. These drugs are used to treat breast cancer that has all of the following characteristics:</p>
















<ul>
<li>
<strong>Hormone receptor-positive or hormone receptor-negative</strong>. These cancer cells may or may not have receptors (attachment sites) for estrogen or progesterone.</li>
















<li>
<strong>Mutations in BRCA1 or BRCA2 genes (types of breast cancer genes)</strong>. These mutations (abnormal changes) increase the risk of having certain types of cancer. Cancer with BRCA gene mutations is called BRCA-positive.</li>
















<li>
<strong>HER2-negative breast cancer</strong>. These cancer cells don't have HER2 (human epidermal growth factor receptor 2) proteins on their surface.</li>
















<li>
<strong>Advanced disease</strong>. This type of cancer has spread near your breast (called locally advanced disease) or to other parts of your body (called metastatic disease).</li>
















</ul>
<p>(See the "Talzenna for breast cancer" section above for more information about this type of cancer.)</p>
















<p>Lynparza is approved for use in people whose breast cancer hasn't responded well enough to chemotherapy drugs.</p>
















<p>Lynparza is also approved as:</p>
















<ul>
<li>maintenance treatment of BRCA-mutated advanced ovarian cancer</li>
















<li>maintenance treatment of recurrent ovarian cancer</li>
















<li>treatment of advanced BRCA-mutated ovarian cancer, in people whose cancer hasn't responded well enough to three or more different chemotherapy drugs</li>
















</ul>
<h3>Drug forms and administration</h3>
















<p>Talzenna comes as capsules, which are available in two strengths: 0.25 mg and 1 mg. The usual recommended dosage of Talzenna is 1 mg taken by mouth once daily.</p>
















<p>Lynparza comes as a tablets, which are available in two strengths: 150 mg and 100 mg. The usual recommended dosage of Lynparza is 300 mg taken by mouth twice daily.</p>
















<p>The dosage of Talzenna and Lynparza may need to be lowered in some people. Your doctor may lower your dosage if you have kidney disease, side effects that can't be managed, or drug interactions with other medications you're taking.</p>
















<h3>Side effects and risks</h3>
















<p>Talzenna and Lynparza contain different drugs, but they act in similar ways in your body. Therefore, both medications can cause very similar side effects and some different side effects. Below are examples of these side effects.</p>
















<p><strong>More common side effects</strong></p>
















<p>These lists contain examples of more common side effects that can occur with Talzenna, with Lynparza, or with both drugs (when taken individually).</p>
















<ul>
<li>
<strong>Can occur with Talzenna</strong>:</li>
















<ul>
<li>hair loss</li>
















</ul>
<li>
<strong>Can occur with Lynparza</strong>:</li>
















<ul>
<li>stomach pain or upset</li>
















<li>dizziness</li>
















<li>upper respiratory infections, such as common cold or <a href="/articles/149941.php" title="Everything you need to know about sinusitis" class="keywords">sinusitis</a>
</li>
















<li>sores in your mouth or on your lips</li>
















<li>impaired taste</li>
















</ul>
<li>
<strong>Can occur with both Talzenna and Lynparza</strong>:</li>
















<ul>
<li>nausea</li>
















<li>diarrhea</li>
















<li>fatigue (lack of energy)</li>
















<li>headache</li>
















<li>loss of appetite</li>
















<li>vomiting</li>
















</ul>
</ul>
<p><strong>Serious side effects</strong></p>
















<p>These lists contain examples of serious side effects that can occur with Talzenna, with Lynparza, or with both drugs (when taken individually).</p>
















<ul>
<li>
<strong>Can occur with Talzenna</strong>:</li>
















<ul>
<li>few unique serious side effects</li>
















</ul>
<li>
<strong>Can occur with Lynparza</strong>:</li>
















<ul>
<li>pneumonitis (<a href="/articles/248423.php" title="Everything you need to know about inflammation" class="keywords">inflammation</a> in your lungs)</li>
















</ul>
<li>
<strong>Can occur with both Talzenna and Lynparza</strong>:</li>
















<ul>
<li>anemia (low red blood cells)</li>
















<li>thrombocytopenia (low platelets)</li>
















<li>neutropenia (low white blood cells)</li>
















<li>myelodysplastic syndrome/acute myeloid leukemia (cancer in your blood or bone marrow)</li>
















</ul>
</ul>
<h3>Effectiveness</h3>
















<p>Talzenna and Lynparza have different FDA-approved uses, but they're both used to treat HER2-negative, BRCA-positive, metastatic breast cancer.</p>
















<p>These drugs haven't been directly compared in clinical studies. However, studies have found that <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a#S5.1" target="_blank" rel="noopener">Talzenna</a> and <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=741ff3e3-dc1a-45a6-84e5-2481b27131aa" target="_blank" rel="noopener">Lynparza</a> are each effective for treating this type of breast cancer.</p>
















<p>According to <a href="https://www.nccn.org/about/news/ebulletin/ebulletindetail.aspx?ebulletinid=1549" target="_blank" rel="noopener">treatment guidelines</a>, Lynparza and Talzenna are both first-choice options for people with HER2-negative, BRCA-positive, metastatic breast cancer.</p>
















<h3>Costs</h3>
















<p>Talzenna and Lynparza are both brand-name drugs. There are currently no generic forms of either drug. Brand-name medications usually cost more than generics.</p>
















<p>According to estimates on <a href="https://www.wellrx.com/" target="_blank" rel="noopener">WellRx.com</a>, Talzenna and Lynparza generally cost about the same. The actual price you'll pay for either drug depends on your dose, your insurance plan, and the pharmacy you use.</p>
















<span class="anchor" id="how-to-take"></span>
<!--[DLB]--><div id="hl-incontent-video-ad"></div>
<div id="div-gpt-ad-out-of-page"></div>
<script type="text/javascript">
	googleAdSlotInfo.push({
		"slotName":'out-of-page',
		"slotContainer":'div-gpt-ad-out-of-page'	});
</script><!--[END DLB]--><!--[MMR]--><!--[END MMR]--><h2>How to take Talzenna</h2>
















<p>You should take Talzenna according to your doctor or healthcare provider's instructions.</p>
















<h3>When to take</h3>
















<p>Talzenna should be taken once daily, around the same time each day.</p>
















<h3>Taking Talzenna with food</h3>
















<p>Talzenna can be taken with or without food.</p>
















<h3>Can Talzenna be crushed?</h3>
















<p>No, Talzenna capsules shouldn't be crushed. They should be swallowed whole so that the drug is released into your body over the right amount of time.</p>
















<p>If you have trouble swallowing pills, talk to your doctor about other treatment options or ways to make swallowing your pills easier for you.</p>
















<span class="anchor" id="how-it-works"></span>
<h2>How Talzenna works</h2>
















<p>Talzenna contains the active drug talazoparib. It belongs to a drug class called poly ADP-ribose polymerase (PARP) inhibitors. It's used to treat HER2-negative, BRCA-positive breast cancer that's either locally advanced (spread near your breast) or metastatic (spread to other areas of your body).</p>
















<h3>About this type of breast cancer</h3>
















<p>Talzenna is used to treat a certain forms of breast cancer that have all of the following characteristics:</p>
















<ul>
<li>
<strong>Hormone receptor-positive or hormone receptor-negative</strong>. These cancer cells may or may not have receptors (attachment sites) for estrogen or progesterone.</li>
















<li>
<strong>Mutations in BRCA1 or BRCA2 genes (types of breast cancer genes)</strong>. These mutations (abnormal changes) increase the risk of having certain types of cancer. Cancer with BRCA gene mutations is called BRCA-positive.</li>
















<li>
<strong>HER2-negative breast cancer</strong>. These cancer cells don't have HER2 (human epidermal growth factor receptor 2) proteins on their surface.</li>
















<li>
<strong>Advanced disease</strong>. This type of cancer has spread near your breast (called locally advanced disease) or to other parts of your body (called metastatic disease).</li>
















</ul>
<h3>What Talzenna does</h3>
















<p>Cancer cells typically grow rapidly inside your body. The process of growing (making more cancer cells) can lead to damage in DNA (genetic material) inside the cells. Cells use enzymes (certain proteins) to help repair their DNA so that more cells can be made.</p>
















<p>Talzenna works by blocking the activity of PARP, which is one of the enzymes that helps cells repair their broken DNA.</p>
















<p>Talzenna is used to treat breast cancer in people who have mutated BRCA genes. The BRCA gene is also involved in DNA repair inside cells, but it works in a different way than PARP. People with mutated BRCA genes can't repair some forms of DNA damage in their cells.</p>
















<p>Blocking PARP in people with mutated BRCA genes helps stop two ways that cells are able to repair their DNA. This leads to more damaged DNA in the cells. When the DNA becomes too damaged, chemical messengers in your body tell the cells to die.</p>
















<p>By preventing DNA repair, Talzenna helps decrease the number of cancer cells in your body. This slows the growth and spread of breast cancer.</p>
















<h3>How long does it take to work?</h3>
















<div id="threequarter-of-article"></div>
<p>Talzenna starts working in your body shortly after you take it. However, the goal of Talzenna treatment is to stop the growth of cancer. It's not possible to say for sure how quickly the drug will stop cancer cells from growing and spreading.</p>
















<p>In a <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1802905" target="_blank" rel="noopener">clinical study</a> of people taking Talzenna, the drug was effective for some people. In these people, about 45% had a smaller <a href="/articles/249141.php" title="What are the different types of tumors?" class="keywords">tumor</a> size 49 days after they started taking Talzenna. Not everyone in this study had a response to treatment.</p>
















<p>Your doctor will discuss ways to monitor your progress during treatment. This will help you know if the drug is working for you.</p>
















<span class="anchor" id="pregnancy"></span>
<h2>Talzenna and pregnancy</h2>
















<p>There haven't been enough studies in humans to know if Talzenna is safe to take during pregnancy. However, <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a#S5.1" target="_blank" rel="noopener">animal studies</a> did show harm (including skeletal malformations and death) to the fetus when the mother received the drug during pregnancy. Keep in mind that animal studies don't always predict how a drug will affect humans.</p>
















<p>Before you start treatment with Talzenna, your doctor will recommend a pregnancy test if you're a women of child-bearing age. If you're pregnant, you may not be able to take Talzenna. Your doctor will likely recommend that you wait until after you give birth before you start treatment with the drug.</p>
















<span class="anchor" id="birth-control-needs"></span>
<h2>Talzenna and birth control</h2>
















<p>Because Talzenna can be harmful to a pregnancy, it's important to prevent pregnancy while using this drug.</p>
















<p>Women of childbearing-age who are taking Talzenna should use <a href="/articles/162762.php" title="What types of birth control are there?" class="keywords">birth control</a> (contraception) during treatment. They should continue to use contraception for at least seven months after their last dose of Talzenna.</p>
















<p>Men taking Talzenna who are sexually active with females who could become pregnant should also use birth control (such as condoms) during treatment. They should continue to use contraception for at least four months after their last dose. This is important even if their female partner is using birth control.</p>
















<span class="anchor" id="breastfeeding"></span>
<!--[MMR]--><!--[END MMR]--><h2>Talzenna and breastfeeding</h2>
















<p>It's not known if Talzenna passes into human breast milk. However, breastfeeding while taking Talzenna isn't recommended. This is because Talzenna's side effects could be serious if the drug is consumed in breast milk by a child. You should wait one full month after receiving your last dose of Talzenna before breastfeeding.</p>
















<p>If you're considering Talzenna treatment while breastfeeding, talk to your doctor about other healthy ways to feed your child.</p>
















<span class="anchor" id="faqs"></span>
<h2>Common questions about Talzenna</h2>
















<p>Here are answers to some frequently asked questions about Talzenna.</p>
















<h3>Is Talzenna a type of chemotherapy?</h3>
















<p>No, Talzenna isn't considered a type of chemotherapy (standard drugs used to treat cancer). Chemotherapy drugs work differently than Talzenna does.</p>
















<p>Chemotherapy drugs work by killing or stopping the growth of rapidly growing cells, such as cancer cells. Chemotherapy drugs are active against all fast-growing cells, which means they can affect noncancerous (healthy) cells in your body. Common areas of your body that may be affected by chemotherapy drugs include your hair follicles and the lining of your intestines.</p>
















<p>Talzenna works differently than chemotherapy. It's a type of targeted therapy that is designed to attack specific cancer cells or certain parts of cancer cells. Because targeted drugs are made to work on specific substances, they may do less harm to normal cells in your body.</p>
















<h3>Can I use this drug if I've had a mastectomy?</h3>
















<p>Yes, you can. If you need additional treatment after you've had a <a href="/articles/302035.php" title="What is a mastectomy?" class="keywords">mastectomy</a>, your doctor may consider prescribing Talzenna or other cancer treatments.</p>
















<h3>Can Talzenna be used for males and females?</h3>
















<p>Yes. Talzenna can be used for males or females with certain types of breast cancer.</p>
















<p>In the <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a#S5.1" target="_blank" rel="noopener">clinical study</a> used for Talzenna's FDA approval, 1.6% of people taking Talzenna were male. In the general population, breast cancer is less common in men than in women.</p>
















<span class="anchor" id="warnings"></span>
<!--[DLB]--><!-- Leaderboard BANNER advert -->

<div id="dlb3_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb3_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB3',
			"slotContainer":'dlb3_container'		});
	</script>
	</div>
	

</div>






<!-- /header_ad code --><!--[END DLB]--><h2>Talzenna warnings</h2>
















<p>Before taking Talzenna, talk with your doctor about your health history. Talzenna may not be right for you if you have the following medical condition:</p>
















<ul>
<li>
<strong>Blood disorders</strong>. Talzenna can cause decreased levels of certain blood cells, including red blood cells, white blood cells, and platelets. These conditions can increase your risk of infections, bleeding, and anemia. Blood disorders may be associated with certain blood cancers (myelodysplastic syndrome/acute myeloid leukemia). If you have low levels of certain blood cells before treatment, your doctor will wait to start treatment until your blood counts have returned to a healthy level.</li>
















</ul>
<p>Note: For more information about the potential negative effects of Talzenna, see the "Talzenna side effects" section above.</p>
















<span class="anchor" id="overdose"></span>
<h2>Talzenna overdose</h2>
















<p>Taking too much Talzenna can increase your risk of serious side effects. It can also make common side effects worse.</p>
















<h3>Overdose symptoms</h3>
















<p>Symptoms of an overdose can include:</p>
















<ul>
<li>diarrhea</li>
















<li>nausea</li>
















<li>vomiting</li>
















<li>lack of appetite</li>
















<li>headache</li>
















<li>fatigue (lack of energy)</li>
















</ul>
<h3>What to do in case of overdose</h3>
















<p>If you think you've taken too much of this drug, call your doctor or seek guidance from the American Association of Poison Control Centers at 800-222-1222 or through their <a href="https://www.poisonhelp.org/help" target="_blank" rel="noopener">online tool</a>. <strong>But if your symptoms are severe, call 911 or go to the nearest emergency room right away</strong>.</p>
















<span class="anchor" id="expiration"></span>
<!--[MMR]--><!--[END MMR]--><h2>Talzenna expiration, storage, and disposal</h2>
















<p>When you get Talzenna from the pharmacy, the pharmacist will add an expiration date to the label on the bottle. This date is typically one year from the date they dispensed the medication.</p>
















<p>The expiration date helps guarantee the effectiveness of the medication during this time. The current stance of the Food and Drug Administration (FDA) is to avoid using expired medications. If you have unused medication that has gone past the expiration date, talk to your pharmacist about whether you might still be able to use it.</p>
















<h3>Storage</h3>
















<p>How long a medication remains good can depend on many factors, including how and where you store the medication.</p>
















<p>Talzenna capsules should be stored at room temperature (68°F to 77°F/20°C to 25⁰C) in a tightly sealed container away from light. Avoid storing this medication in areas where it could get damp or wet, such as bathrooms.</p>
















<h3>Disposal</h3>
















<p>If you no longer need to take Talzenna and have leftover medication, it's important to dispose of it safely. This helps prevent others, including children and pets, from taking the drug by accident. It also helps keep the drug from harming the environment.</p>
















<p>The FDA website provides several useful tips on medication disposal. You can also ask your pharmacist for information on how to dispose of your medication.</p>
















<span class="anchor" id="for-professionals"></span>
<h2>Professional information for Talzenna</h2>
















<p>The following information is provided for clinicians and other healthcare professionals.</p>
















<h3>Indications</h3>
















<p>Talzenna (talazoparib) is indicated for the treatment of breast cancer with each of the following characteristics:</p>
















<ul>
<li>deleterious or suspected deleterious mutated BRCA (gBRCAm)</li>
















<li>human epidermal growth factor receptor 2 (HER2)-negative</li>
















<li>locally advanced or metastatic disease</li>
















<li>hormone receptor-positive or hormone receptor-negative</li>
















</ul>
<h3>Mechanism of action</h3>
















<p>Talzenna is a poly ADP-ribose polymerase (PARP) inhibitor. Talzenna inhibits both PARP1 and PARP2, enzymes involved in DNA repair. Blocking PARP enzymes prevents cancer cells from repairing DNA, which ultimately leads to DNA damage, decreased cell proliferation, and cancer cell apoptosis.</p>
















<h3>Pharmacokinetics and metabolism</h3>
















<p>Time to maximum concentration is approximately one to two hours following oral administration. Steady-state concentrations are reached in two to three weeks.</p>
















<p>Metabolism occurs via oxidation, dehydrogenation, and conjugation, with minimal hepatic involvement. Mean terminal half-life is 90 hours. Elimination occurs primarily in the urine (~68.7%) and feces (~19.7%).</p>
















<p>Moderate renal impairment increases exposure and requires a dose adjustment.</p>
















<h3>Contraindications</h3>
















<p>There are no absolute contraindications to Talzenna use.</p>
















<h3>Storage</h3>
















<p>Talzenna should be stored at room temperature (68°F to 77°F/20°C to 25°C).</p>
















<p><strong>Disclaimer</strong>: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up-to-date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or other healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.</p>
<div id="bottom-of-article"></div>
 	</div> 	</div> 
<style type="text/css">
		/*.mnt_dlb_foot_container { display:block; width: 728px; height: 90px; }*/
		/*@media (min-width: 990px) { .mnt_dlb_foot_container { display: none; } }
		@media (min-width:1148px) { .mnt_dlb_foot_container { display:block;} }*/
</style>
<!-- MNT_Adsense_Desktop_728x90 Footer -->
<ins class="adsbygoogle mnt_dlb_foot_container"
	 id="mnt_dlb_foot_container"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-4771166113579725"
     data-ad-slot="9436500920"></ins>


<script>


	fireOrSaveJsFunctions(1,function(){loadScript(
		"//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js",
		{},
		function(){}

	)});


</script>
<script>(adsbygoogle = window.adsbygoogle || []).push({});</script>



<p id='slidebox_trigger'></p>

	<div id="suggest_reading_outer_container" class="place full">

		<h2 class="suggested_reading internal_related">Related coverage</h2>
	<span></span>
		<!--<h2 class="suggested_reading">Suggested Reading</h2>-->
	
	<div itemscope itemtype="http://schema.org/WebPage"> <!-- suggested_reading_container_parent -->
	<div class="suggested_reading_container ">
				<div class='suggested_reading_inner column1'>
				<div class="suggested_item">
		<a href="/articles/324272.php" title="Triple-negative breast cancer: Recurrence and survival rates" class="related_coverage_link" data-id="324272">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/324/324272/324272_1100.jpg" alt="" />
		</div>
				<span class="title">Triple-negative breast cancer: Recurrence and survival rates</span>
		<span class="summary">Triple-negative breast cancer is an aggressive form of breast cancer. It can recur more frequently than other types. This article looks at the recurrence rates, survival statistics, treatment, and prevention of triple-negative breast cancer.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column2'>
				<div class="suggested_item">
		<a href="/articles/325756.php" title="What to know about proton therapy for breast cancer" class="related_coverage_link" data-id="325756">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/325/325756/325756_1100.jpg" alt="" />
		</div>
				<span class="title">What to know about proton therapy for breast cancer</span>
		<span class="summary">Proton therapy is a type of radiation that can treat cancers, including breast cancer. This article discusses its uses, effectiveness, and procedure.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column3'>
				<div class="suggested_item">
		<a href="/articles/325625.php" title="Which natural treatments can help people with breast cancer?" class="related_coverage_link" data-id="325625">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/325/325625/325625_1100.jpg" alt="" />
		</div>
				<span class="title">Which natural treatments can help people with breast cancer?</span>
		<span class="summary">A number of natural and complementary therapies can help support a person’s mind and body during breast cancer treatment and may also help alleviate medication side effects. However, these therapies cannot replace standard treatment for breast cancer. Learn more here. </span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column4'>
				<div class="suggested_item">
		<a href="/articles/37136.php" title="What to know about breast cancer" class="related_coverage_link" data-id="37136">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/037/37136/37136_1100.jpg" alt="" />
		</div>
				<span class="title">What to know about breast cancer</span>
		<span class="summary">Breast cancer survival rates are rising as screening and treatment improve. However, breast cancer is still the most invasive cancer in women. Read on to learn more. </span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column5'>
				<div class="suggested_item">
		<a href="/articles/324318.php" title="What to know about multifocal breast cancer" class="related_coverage_link" data-id="324318">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/324/324318/324318_1100.jpg" alt="" />
		</div>
				<span class="title">What to know about multifocal breast cancer</span>
		<span class="summary">Multifocal breast cancer is where a person has more than one tumor in one area of their breast. In this article, we look at the causes, diagnosis, staging, treatment, and prognosis for multifocal breast cancer. </span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
				</div>
	</div>
	</div>
	

<div id="social_bottom"  >			
    <div id="share_social_bottom">    
        <div id="article_social_bottom_facebook" ></div>
        <div id="article_social_bottom_twitter" ></div>
        <div id="article_social_bottom_linkedin" ></div>

		    
    </div>
    <div class="toolbox">
		<div class="email">            <a rel="nofollow" title="email this article" href="#">
			<span class="toolbox_label">email</span></a>
            <span class="visuallyhidden">
            <a rel="nofollow" title="email this article" href="#">email</a>
            </span>
        </div>        
		        <div class="print">			            <a id="8708d769005c477c073cd77f6895718b" href="#" rel="nofollow" title="View print preview" target="_blank">
			<span class="toolbox_label">print</span></a>
        </div>        		
		<div class="share">            <a rel="nofollow" title="share this article" href="#">
			<span class="toolbox_label">share</span></a>
            <span class="visuallyhidden">
            <a rel="nofollow" title="share this article" href="#">share</a>
            </span>
        </div>

    </div>

</div><a id="rate-this-article"></a>	<div class="article_category_container">
					<div class="article_main_category_container"> 
				<span itemprop="genre" class="category_main">
				<a href="/categories/breast_cancer" title="Breast Cancer News" class="current">Breast Cancer</a>
				</span>
			</div> 					<div class="article_sub_category_container">
				</div> 	</div> 	                    <div class="widget_citation_group" id="widget_citation">

                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading active">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#additional">
                                        Additional information</a>
                                </h4>
                            </div>
                            <div id="additional" class="panel-collapse collapse in">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="additional" >

		<p> Article last reviewed by Sun 23 June 2019.<br><br>Visit our <a href='/categories/breast_cancer' title='Visit our Breast Cancer category page'>Breast Cancer</a> category page for the latest news on this subject, or <a href='/newsletter' title='Sign up to our newsletter'>sign up to our newsletter</a> to receive the latest updates on Breast Cancer.<br><br>All references are available in the <b>References</b> tab.		</p>
	</ul>
	                                </div>
                            </div>
                        </div>


                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#references">
                                        References</a>
                                </h4>
                            </div>
                            <div id="references" class="panel-collapse collapse">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="references" >
		<noscript> 
		This content requires JavaScript to be enabled.<br/><br/> 
		</noscript>
		<p>
		<p>The American Cancer Society medical and editorial content team. (2019). Key statistics for breast cancer in men. <a href="https://www.cancer.org/cancer/breast-cancer-in-men/about/key-statistics.html" target="_blank" rel="noopener">https://www.cancer.org/cancer/breast-cancer-in-men/about/key-statistics.html</a></p>
<p>Avelumab and talazoparib in untreated advanced ovarian cancer (JAVELIN OVARIAN PARP 100). (2019). <a href="https://clinicaltrials.gov/ct2/show/NCT03642132" target="_blank" rel="noopener">https://clinicaltrials.gov/ct2/show/NCT03642132</a></p>
<p>Breast cancer treatment (PDQ) - patient version. (2019). <a href="https://www.cancer.gov/types/breast/patient/breast-treatment-pdq" target="_blank" rel="noopener">https://www.cancer.gov/types/breast/patient/breast-treatment-pdq</a></p>
<p>Don't be tempted to use expired medicines. (2016). <a href="https://www.fda.gov/drugs/resourcesforyou/specialfeatures/ucm481139.htm" target="_blank" rel="noopener">https://www.fda.gov/drugs/resourcesforyou/specialfeatures/ucm481139.htm</a></p>
<p>Hoy SM. (2018). Talazoparib: First global approval. <a href="https://link.springer.com/article/10.1007%2Fs40265-018-1026-z" target="_blank" rel="noopener">https://link.springer.com/article/10.1007%2Fs40265-018-1026-z</a></p>
<p>Litton JK, et al. (2018). Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. <a href="https://www.nejm.org/doi/10.1056/NEJMoa1802905" target="_blank" rel="noopener">https://www.nejm.org/doi/10.1056/NEJMoa1802905</a></p>
<p>Lung-MAP: Biomarker-targeted second-line therapy in treating patients with recurrent stage IV squamous cell lung cancer. (2018). <a href="https://clinicaltrials.gov/ct2/show/record/NCT02154490" target="_blank" rel="noopener">https://clinicaltrials.gov/ct2/show/record/NCT02154490</a></p>
<p>Lynparza - olaparib tablet, film coated. (2018). <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=741ff3e3-dc1a-45a6-84e5-2481b27131aa" target="_blank" rel="noopener">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=741ff3e3-dc1a-45a6-84e5-2481b27131aa</a></p>
<p>Male breast cancer. (n.d.). <a href="https://www.nationalbreastcancer.org/male-breast-cancer" target="_blank" rel="noopener">https://www.nationalbreastcancer.org/male-breast-cancer</a></p>
<p>National Cancer Institute Therapy Evaluation Program. Common terminology criteria for adverse events and common toxicity criteria [v4.0]. (2010). <a href="https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf" target="_blank" rel="noopener">https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf</a></p>
<p>NCCN clinical practice guidelines in oncology: Breast cancer. (2019). <a href="https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf" target="_blank" rel="noopener">https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf</a></p>
<p>NCCN flash updates: NCCN guidelines and NCCN compendium for breast cancer. (2018). <a href="https://www.nccn.org/about/news/ebulletin/ebulletindetail.aspx?ebulletinid=1549" target="_blank" rel="noopener">https://www.nccn.org/about/news/ebulletin/ebulletindetail.aspx?ebulletinid=1549</a></p>
<p>NCCN guidelines for patients: Breast cancer - invasive. (2018). <a href="https://www.nccn.org/patients/guidelines/breast-invasive/index.html" target="_blank" rel="noopener">https://www.nccn.org/patients/guidelines/breast-invasive/index.html</a></p>
<p>NCCN guidelines for patients: Breast cancer - metastatic. (2018). <a href="https://www.nccn.org/patients/guidelines/stage_iv_breast/index.html" target="_blank" rel="noopener">https://www.nccn.org/patients/guidelines/stage_iv_breast/index.html</a></p>
<p>Talazoparib + enzalutamide vs. enzalutamide monotherapy in mCRPC (TALAPRO-2). (2019) <a href="https://clinicaltrials.gov/ct2/show/NCT03395197" target="_blank" rel="noopener">https://clinicaltrials.gov/ct2/show/NCT03395197</a></p>
<p>Talzenna - talazoparib capsule. (2018). <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a" target="_blank" rel="noopener">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a</a></p>
<p>WellRx. (n.d.). <a href="https://www.wellrx.com/" target="_blank" rel="noopener">https://www.wellrx.com/</a></p>		</p>
	</ul>
	                                </div>
                            </div>
                        </div>


                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#citations">
                                        Citations</a>
                                </h4>
                            </div>
                            <div id="citations" class="panel-collapse collapse">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="citations" >
		<p>Please use one of the following formats to cite this article in your essay, paper or report:</p><p><strong>MLA</strong><br />Slowiczek, Lindsay. "Talzenna (talazoparib)." <i>Medical News Today</i>. MediLexicon, Intl., 15 Aug. 2019. Web.<br>6 Sep. 2019. &lt;https://www.medicalnewstoday.com/articles/325689.php&gt;</p><hr size="1" /><p><strong>APA</strong><br />Slowiczek, L. (2019, August 15). "Talzenna (talazoparib)." <i>Medical News Today</i>. Retrieved from<br><a href='https://www.medicalnewstoday.com/articles/325689.php' itemprop='url'>https://www.medicalnewstoday.com/articles/325689.php</a>.</p><hr size="1" /><p>Please note: If no author information is provided, the source is cited instead.</p>	</ul>
	                                </div>
                            </div>
                        </div>

                    </div>


					
	<hr class="nonprint"/>
<div class="article_email">
	<div id="header_close_button" class="email_close"></div>
	<div class="emailform_container">

	</div>
</div></div>  
</article>

	<div class="col-xs-12 col-sm-12 col-md-4 col-lg-4 sidebar"> 
<!-- article_ad code -->
<!-- MREC ARTICLE advert -->
<div id="dmr1_container" class="mnt css_hs211">

<div class="mnt_history" style="display:none;">
	<a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_knowledge_center_001.png" alt="MNT Knowledge Center" /></a>
 	

</div>

		<div id='dmr1_unit' adonis-marker>
		<script type='text/javascript'>
			googleAdSlotInfo.push({
				"slotName":'DMR1',
				"slotContainer":'dmr1_container'			});
		</script>
		</div>
		<span class='bt-uid-tg' data-uid='5b84643d24-160' style='display: none !important'></span></div> <!-- /article_ad code -->
	<div id="sidebar_feature" class="full">
			<h2>Latest news</h2>
		<span></span>
	<ul class="sidebar_feature">
	<li>	<a href="/articles/326281.php" title="Curiosities of medical history: Trepanation">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326281/326281_1100.jpg" alt="Curiosities of medical history: Trepanation" class="original">
	<div class="headline">Curiosities of medical history: Trepanation</div> 
	<div class="excerpt">Trepanation is the historical practice of drilling holes into the skull. But why did our ancestors do it, and when did it start? We investigate.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326278.php" title="Scientists identify genetic components of left-handedness">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326278/326278_1100.jpg" alt="Scientists identify genetic components of left-handedness" class="original">
	<div class="headline">Scientists identify genetic components of left-handedness</div> 
	<div class="excerpt">In a genetic analysis of 400,000 people, scientists have, for the first time, identified four DNA regions associated with left-handedness.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326243.php" title="World first: Doctors use 'reprogrammed' stem cells to repair cornea">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326243/326243_1100.jpg" alt="World first: Doctors use 'reprogrammed' stem cells to repair cornea" class="original">
	<div class="headline">World first: Doctors use 'reprogrammed' stem cells to repair cornea</div> 
	<div class="excerpt">In a groundbreaking procedure, surgeons have successfully repaired a human cornea using 'reprogrammed' cells from the patient's skin. </div>
	</div>

	</a></li>
	<li>	<a href="/articles/326232.php" title="Inflammation in late teens linked to mortality risk decades later">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326232/326232_1100.jpg" alt="Inflammation in late teens linked to mortality risk decades later" class="original">
	<div class="headline">Inflammation in late teens linked to mortality risk decades later</div> 
	<div class="excerpt">Experts know little about how inflammation in early life affects health later on. A new study links teen inflammation to mortality risk 35 years later.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326271.php" title="Scientists identify a trigger for type 1 diabetes in mice">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326271/326271_1100.jpg" alt="Scientists identify a trigger for type 1 diabetes in mice" class="original">
	<div class="headline">Scientists identify a trigger for type 1 diabetes in mice</div> 
	<div class="excerpt">Scientists discover a previously unknown switch that causes immune cells to begin destroying insulin, resulting in the onset of type 1 diabetes. </div>
	</div>

	</a></li>
		</ul>
	</div>
		<!-- article_ad code -->
<!-- MREC ARTICLE advert -->
<div id="dmr2_container" class="mnt css_hs211">

<div class="mnt_history" style="display:none;">
	<a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_knowledge_center_001.png" alt="MNT Knowledge Center" /></a>
 	

</div>

		<div id='dmr2_unit' adonis-marker>
		<script type='text/javascript'>
			googleAdSlotInfo.push({
				"slotName":'DMR2',
				"slotContainer":'dmr2_container'			});
		</script>
		</div>
		<span class='bt-uid-tg' data-uid='5b846454f2-160' style='display: none !important'></span></div> <!-- /article_ad code -->
	<div class="full popular_tabs_container"> 	<div class="full popular_tabs_parent"> 	<h2 class="popular_tabs_heading"><span>Popular in: </span>Breast Cancer</h2><span></span>
	<div id="popular_tabs">
	<div class="centered">
	
	<ul class="nav">
		</ul>
	
			<div class="list-wrap">
					<ul id="popular-read">
				<li class="knowledge">
	<a href="/articles/37136.php" title="What to know about breast cancer">
		<span class="headline">
	What to know about breast cancer	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/323824.php" title="End-of-life symptoms of metastatic breast cancer">
		<span class="headline">
	End-of-life symptoms of metastatic breast cancer	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/324314.php" title="Breast cancer: How fast does it spread?">
		<span class="headline">
	Breast cancer: How fast does it spread?	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/323177.php" title="Life expectancy for stage 3 breast cancer">
		<span class="headline">
	Life expectancy for stage 3 breast cancer	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/324272.php" title="Triple-negative breast cancer: Recurrence and survival rates">
		<span class="headline">
	Triple-negative breast cancer: Recurrence and survival rates	</span>
		</a></li>
				<span></span> 			</ul>
					</div> <!-- /list_wrap -->
			</div> <!-- /the_tabs -->
	</div> <!-- /centered -->
	</div> 	</div> 	</div> <!-- /sidebar -->
</div> 
</div> 


	<img height="1" width="1" src="https://d.turn.com/r/dd/id/L21rdC84MTYvY2lkLzE3NDc2NjAwNjEvdC8y/kv/CampaignID=MedicalNewsToday,Content=breastcancer">

<div id="message"><a href="#top" style="display: none;">Scroll to top</a></div>


<footer>

<div class="container">

	<div class="row"> 	
		<div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 footer"> 		
			<div id="footer_logo">
				<a href="/"  title="Medical News Today : Home">
					<img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-mini-2017.png" alt="MNT home">
				</a>
			</div> 				
			<div id="footer_social">
				<span class="footer_facebook fa-stack fa-lg">
				<a href="https://www.facebook.com/MedicalNewsToday" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-facebook fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_twitter fa-stack fa-lg">
				<a href="https://twitter.com/mnt" target="_blank" rel="noopener noreferrer">
				<i class="fa fa-twitter fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_linkedin fa-stack fa-lg">
				<a href="https://www.linkedin.com/company/mednewstoday" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-linkedin fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_pinterest fa-stack fa-lg">
				<a href="https://www.pinterest.com/search/pins/?q=www.medicalnewstoday.com" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-pinterest fa-stack-1x fa-inverse"></i>
				</a></span>
			</div> 		
			<div id="footer_list">
				<ul>
								<li><a href="/popular" title="View our most popular news articles">Popular news</a></li>
				<li><a href="/archive" title="View all our editorial articles">Editorial articles</a></li>
				<li><a href="/categories" accesskey="m" title="View our complete news category list">All news topics</a></li>
				<li><a href="/knowledge-center" title="Medical conditions and information center">Knowledge center</a></li>

								<li><a href="/newsletter" title="Medical News Today in your inbox">Newsletters</a></li>


					
				<li><a href="/share-our-content" title="Share our content">Share our content</a></li>

								<li><a href="/about" title="About Medical News Today">About us</a></li>
				<li><a href="/authors" title="Our editorial team">Our editorial team</a></li>
				<li><a href="/contact" title="Contact the Medical News Today team">Contact us</a></li>
				<li><a href="/advertising" title="Advertise with Medical News Today">Advertise with MNT</a></li>
				</ul>
			</div> 				
			<span class="footer_separator">
				<span></span>
			</span> 			
			<div id="footer_newsletter">
					<h3 id="footer_newsletter_h3">get our newsletter</h3>
					<span id="footer_newsletter_span">Health tips, wellness advice and more.</span>
					
					<div class="form-group">
						<form method="post" action="#" name="footerNewsletterSignup" id="footerNewsletterSignup" class="newsletterForm">
						<div>
							<input type="text" name="formEmail" id="EmailAddress" class="newsletterFormEmail" placeholder="Enter your email address" size="25" maxlength="150"/>

							<button type="button"
									data-signup-source="footer_newsletter_link"
									class="btn btn-success btn-lg btn-block btn-footer footer_newsletter_link email-signup-btn new_reg_signup">Subscribe</button>

							<div id="footerNewsletterErrorHolder" class="errorHolder"></div>
							

<p>Your <a href="/privacy-policy" title="Privacy policy">privacy</a> is important to us.</p>

						</div>


						</form>

					</div> 				
			</div> 			
			<span class="footer_separator">
				<span></span>
			</span> 			
			<div id="copyright">
				<div class="honcode_img">
				<a href="https://www.healthonnet.org/HONcode/Conduct.html?HONConduct391155" class="seal" onclick="window.open(this.href); return false;">
				<img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://www.honcode.ch/HONcode/Seal/HONConduct391155_s1.gif" alt="This website is certified by Health On the Net Foundation. Click to verify."></a>
				</div> 				<div class="copyright_text float_left">
					<p>Healthline Media UK Ltd, Brighton, UK.</p>
					<p>&copy; 2004-2019 All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.</p>
				</div> 				<div class="copyright_text float_right">
					<p><a href="/privacy-policy" title="View our privacy policy" onclick="fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'New Header - Desktop - Footer', eventAction: 'Footer - Privacy policy', eventLabel: 'Footer - Privacy policy' });});" >Privacy</a> |
					<a href="/terms" title="View our terms of use" onclick="fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'New Header - Desktop - Footer', eventAction: 'Footer - Terms', eventLabel: 'Footer - Terms' });});">Terms</a> |
					<a href="/ad-policy" title="View our advertising policy">Ad policy</a> | 
					<a href="https://www.healthline.com/health/careers" title="Careers" rel="noopener" target="_blank">Careers</a></p>
				</div> 			</div> 			
			<div class="footer_truste_container">
				<div class="footer_truste"><a href="//privacy.truste.com/privacy-seal/validation?rid=b59e7a69-59cd-449f-9af4-2bdba7d346e5" rel="noopener noreferrer" target="_blank"><img style="border: none" src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="//privacy-policy.truste.com/privacy-seal/seal?rid=b59e7a69-59cd-449f-9af4-2bdba7d346e5" alt="TRUSTe"></a></div>
			</div> 			
		</div> 	
				
	</div> 
</div> 
<footer>

<div id="print_message">
	<p>This page was printed from: <strong><a href="https://www.medicalnewstoday.com/articles/325689.php">https://www.medicalnewstoday.com/articles/325689.php</a></strong></p>
	<p>Visit <strong><a href="https://www.medicalnewstoday.com">www.medicalnewstoday.com</a></strong> for medical news and health news headlines posted throughout the day, every day.</p>
	<hr/>
	<p>2019 Healthline Media UK Ltd. All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.</p>
</div> 



<script type="text/javascript">
		eval(function(p,a,c,k,e,d){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};if(!''.replace(/^/,String)){while(c--){d[e(c)]=k[c]||e(c)}k=[function(e){return d[e]}];e=function(){return'\\w+'};c=1};while(c--){if(k[c]){p=p.replace(new RegExp('\\b'+e(c)+'\\b','g'),k[c])}}return p}('3 j=d.1i(\'.A-1p 8\');4(j&&j.c("b-7")){j.7=j.c("b-7");j.1r(\'b-7\')}3 9=[].v.w(d.o(\'8[b-7]\'));3 Q=5(q,g){4(q.g==""){q.g=g}B{3 1d=q.g.1s(" ");4(1d.u(g)==-1){q.g+=" "+g}}};1j(3 i=0;i<9.L;i++){4(9[i].1e.1e.p[0]==\'1n\'){Q(9[i],"A-f")}B{Q(9[i],"f")}}d.m("1t",5(){9=[].v.w(d.o(\'8.A-f\'));9.t(5(2){2.7=2.c("b-7");2.p.D("A-f")});9=[].v.w(d.o(\'8.f\'));3 16=18 6!=="1D";3 13=16&&!("1x"n 6)||/(1w|1y|1z)1E|1A|1H/i.1G(1I.1l);4(13){9.t(5(2){2.7=2.c("b-7");2.p.D("f")})}B{4("V"n 6){4(\'F\'n 6&&\'X\'n 6.F.J&&!(\'O\'n F.J)){1C.1q(6.F.J,\'O\',{1B:5(){1h l.X>0}})}3 G=1F V(5(Y,1v){Y.t(5(S){4(S.O){3 2=S.N;2.p.D("f");2.7=2.c("b-7");M(2);G.1m(2)}})},{1k:"T T 1u T"});9.t(5(2){G.1o(2)})}B{3 y;5 h(){9=[].v.w(d.o(\'.f\'));4(y){1Q(y)}y=2g(5(){3 2k=6.2d;9.t(5(8){4((8.W().27-2c<=6.2l&&8.W().2b>=0)&&2a(8).29!=="26"){8.7=8.c("b-7");8.p.D(\'f\');M(8)}});4(9.L==0){d.U("12",h);6.U("11",h);6.U("10",h)}},20)}h();d.m("12",h);6.m("11",h);6.m("10",h)}5 M(2){2.1J=5(){4(2.c(\'b-I-2-x\')){28(2.c(\'b-I-2-x\'),"",R)}4(2.c(\'b-Z-2-x\')){2e(2.c(\'b-Z-2-x\'),"",1a)}}}}3 K=d.o(\'.2j a:2i(.2h)\');1j(3 E=0;E<K.L;E++){3 C=K[E];4(C.s.u(6.1b.s)===-1&&C.s!=""){C.m("I",5(e){4(e.N.g.u("2-2f")>-1){1h 1f}e.24();3 k=l.s;3 P="17 1g - 25 14 15";3 1c=k;3 H=l.1R;3 z=l.1i("8");4(z){H=z.1S||z.1P}3 r=1f;4(18 k!=="1O"&&k.u("1K.1L")===-1){r=R;P="17 1g - 1M 14 15"}4(l.N==="1N"){r=R}4(r){3 19=6.1T(k);19.1U=1a}21(0,5(){22(\'23\',\'1Z\',{1Y:P,1V:H,1W:1c,1X:5(){4(!r){6.1b.s=k}}})})})}}});',62,146,'||image|var|if|function|window|src|img|lazyloadImages||data|getAttribute|document||lazy|className|lazyload||owlCarouselFirstImage|originHref|this|addEventListener|in|querySelectorAll|classList|element|newWindow|href|forEach|indexOf|slice|call|index|lazyloadThrottleTimeout|imageDom|owl|else|linkDOM|remove|articleIndex|IntersectionObserverEntry|imageObserver|gaAction|click|prototype|linksInArticle|length|includeImagePlugin|target|isIntersecting|gaCategory|addLazyClass|true|entry|0px|removeEventListener|IntersectionObserver|getBoundingClientRect|intersectionRatio|entries|sharing|orientationChange|resize|scroll|isBot|Link|Click|runningOnBrowser|Article|typeof|newWnd|null|location|gaLabel|arr|parentNode|false|Body|return|querySelector|for|rootMargin|userAgent|unobserve|item|observe|carousel|defineProperty|removeAttribute|split|DOMContentLoaded|300px|observer|gle|onscroll|ing|ro|crawl|get|Object|undefined|bot|new|test|spider|navigator|onload|medicalnewstoday|com|Outbound|_blank|undefiend|alt|clearTimeout|innerHTML|title|open|opener|eventAction|eventLabel|hitCallback|eventCategory|event||fireOrSaveJsFunctions|ga|send|preventDefault|Internal|none|top|loadClickableImageByIndex|display|getComputedStyle|bottom|300|pageYOffset|loadImageSharingImageByIndex|clickable|setTimeout|collapsed__click|not|article_body|scrollTop|innerHeight'.split('|'),0,{}))

</script>
<script type="text/javascript">
	window.ga=window.ga||function(){};
	if (typeof window.googletag === 'undefined') {
		//Fallback safe for googletag
    	var googletag = googletag || { };
		googletag.cmd = googletag.cmd || [ ];
	}
	
	//Fallback for Adbridg
	if (typeof window.AdBridg === 'undefined') {
		var AdBridg = AdBridg || {};
  		AdBridg.cmd = AdBridg.cmd || [];
	}

</script>







<script type="text/javascript">



		vanillaAjax("https://pavlov-prod.healthline.com/api/metrics","POST",'{"metrics":[{"type":"increment","name":"ui.pageview"}],"build":"1","route":"php","path":"/articles/325689.php","formfactor":"desktop","site":"mnt","abSegment":""}','{"Content-Type":"text\/plain;charset=UTF-8"}');






</script>


<script type="text/javascript" >
			var is_userMobile=0;
			var is_userTablet=0;
			var glob_responsiveOverride=0;
			var glob_customUserID=0;
			var category=[{"displayNavName":"ADHD \/ ADD","url":"adhd"},{"displayNavName":"Allergy","url":"allergy"},{"displayNavName":"Alzheimer's \/ Dementia","url":"alzheimers"},{"displayNavName":"Anxiety \/ Stress","url":"anxiety"},{"displayNavName":"Rheumatology","url":"rheumatology"},{"displayNavName":"Respiratory","url":"respiratory"},{"displayNavName":"Bipolar","url":"bipolar"},{"displayNavName":"Body Aches","url":"bodyaches"},{"displayNavName":"Breast Cancer","url":"breast_cancer"},{"displayNavName":"Cancer \/ Oncology","url":"cancer-oncology"},{"displayNavName":"Cardiovascular \/ Cardiology","url":"cardiovascular"},{"displayNavName":"Caregivers \/ Homecare","url":"caregivers"},{"displayNavName":"Cholesterol","url":"cholesterol"},{"displayNavName":"Crohn's","url":"crohns"},{"displayNavName":"Cystic Fibrosis","url":"cystic_fibrosis"},{"displayNavName":"Depression","url":"depression"},{"displayNavName":"Dermatology","url":"dermatology"},{"displayNavName":"Diabetes","url":"diabetes"},{"displayNavName":"Erectile Dysfunction","url":"erectile_dysfunction"},{"displayNavName":"Fertility","url":"fertility"},{"displayNavName":"Obesity \/ Weight Loss \/ Fitness","url":"fitness-obesity"},{"displayNavName":"Headache \/ Migraine","url":"headache-migraine"},{"displayNavName":"Liver Disease \/ Hepatitis","url":"liver_disease"},{"displayNavName":"HIV and AIDS","url":"hiv-aids"},{"displayNavName":"Hypertension","url":"hypertension"},{"displayNavName":"Irritable Bowel Syndrome","url":"ibs"},{"displayNavName":"Lung Cancer","url":"lung_cancer"},{"displayNavName":"Lymphoma","url":"lymphoma"},{"displayNavName":"Men's Health","url":"mens_health"},{"displayNavName":"Mental Health","url":"mental_health"},{"displayNavName":"Neurology \/ Neuroscience","url":"neurology"},{"displayNavName":"Pregnancy \/ Obstetrics","url":"pregnancy"},{"displayNavName":"Psychology \/ Psychiatry","url":"psychology-psychiatry"},{"displayNavName":"Schizophrenia","url":"schizophrenia"},{"displayNavName":"Seniors \/ Aging","url":"seniors"},{"displayNavName":"Sexual Health \/ STDs","url":"sexual_health"},{"displayNavName":"Statins","url":"statins"},{"displayNavName":"Urology \/ Nephrology","url":"urology-nephrology"},{"displayNavName":"Women's Health","url":"womens_health"},{"displayNavName":"Pediatrics \/ Children's Health","url":"pediatrics"},{"displayNavName":"Radiology \/ Nuclear Medicine","url":"radiology"},{"displayNavName":"Bones \/ Orthopedics","url":"bones"},{"displayNavName":"Public Health","url":"public_health"},{"displayNavName":"Bio-terrorism \/ Terrorism","url":"bioterrorism"},{"displayNavName":"Aid \/ Disasters","url":"aid-disasters"},{"displayNavName":"Genetics","url":"genetics"},{"displayNavName":"Ear, Nose and Throat","url":"ent"},{"displayNavName":"Alcohol \/ Illegal Drugs","url":"alcohol"},{"displayNavName":"Nursing \/ Midwifery","url":"nursing"},{"displayNavName":"Medical Students \/ Training","url":"medical_students"},{"displayNavName":"Pharma \/ Biotech Industry","url":"pharma_industry"},{"displayNavName":"Stem Cell Research","url":"stem_cell"},{"displayNavName":"Dentistry","url":"dentistry"},{"displayNavName":"Bird Flu \/ Avian Flu","url":"birdflu"},{"displayNavName":"MRSA \/ Drug Resistance","url":"mrsa-superbug"},{"displayNavName":"Eye Health \/ Blindness","url":"eye_health"},{"displayNavName":"Tropical Diseases","url":"tropical_diseases"},{"displayNavName":"Cleft Palate","url":"cleft_palate"},{"displayNavName":"Infectious Diseases","url":"infectious_diseases"},{"displayNavName":"Parkinson's Disease","url":"parkinsons_disease"},{"displayNavName":"GastroIntestinal","url":"gastrointestinal"},{"displayNavName":"CJD \/ vCJD \/ Mad Cow Disease","url":"cjd-vcjd"},{"displayNavName":"Nutrition \/ Diet","url":"nutrition-diet"},{"displayNavName":"Gout","url":"gout"},{"displayNavName":"Stroke","url":"stroke"},{"displayNavName":"Complementary Medicine","url":"complementary_medicine"},{"displayNavName":"Endocrinology","url":"endocrinology"},{"displayNavName":"Biology \/ Biochemistry","url":"biology-biochemistry"},{"displayNavName":"Multiple Sclerosis","url":"multiple_sclerosis"},{"displayNavName":"Autism","url":"autism"},{"displayNavName":"Water - Air Quality \/ Agriculture","url":"water_quality"},{"displayNavName":"Immune System \/ Vaccines","url":"immune_system"},{"displayNavName":"Lupus","url":"lupus"},{"displayNavName":"Cosmetic Medicine","url":"cosmetic_medicine"},{"displayNavName":"Rehabilitation","url":"rehabilitation"},{"displayNavName":"Pain \/ Anesthetics","url":"pain"},{"displayNavName":"Hearing \/ Deafness","url":"hearing-deafness"},{"displayNavName":"Muscular Dystrophy \/ ALS","url":"muscular_dystrophy"},{"displayNavName":"Sports Medicine \/ Fitness","url":"sports_medicine"},{"displayNavName":"MRI \/ PET \/ Ultrasound","url":"mri-pet"},{"displayNavName":"Huntingtons Disease","url":"huntingtons_disease"},{"displayNavName":"Medical Devices \/ Diagnostics","url":"medical_devices"},{"displayNavName":"Smoking \/ Quit Smoking","url":"smoking"},{"displayNavName":"Transplants \/ Organ Donations","url":"transplants"},{"displayNavName":"Sleep \/ Sleep Disorders","url":"sleep"},{"displayNavName":"IT \/ Internet \/ E-mail","url":"it"},{"displayNavName":"Dyslexia","url":"dyslexia"},{"displayNavName":"Medicare \/ Medicaid \/ SCHIP","url":"medicare-medicaid"},{"displayNavName":"Epilepsy","url":"epilepsy"},{"displayNavName":"Prostate \/ Prostate Cancer","url":"prostate"},{"displayNavName":"Veterinary","url":"veterinary"},{"displayNavName":"Abortion","url":"abortion"},{"displayNavName":"Health Insurance","url":"health_insurance"},{"displayNavName":"Litigation","url":"medical_malpractice"},{"displayNavName":"Clinical Trials \/ Drug Trials","url":"clinical_trials"},{"displayNavName":"Conferences","url":"conferences"},{"displayNavName":"Compliance","url":"compliance"},{"displayNavName":"Primary Care \/ General Practice","url":"primary_care"},{"displayNavName":"Flu \/ Cold \/ SARS","url":"flu-sars"},{"displayNavName":"Blood \/ Hematology","url":"blood"},{"displayNavName":"Colorectal Cancer","url":"colorectal_cancer"},{"displayNavName":"Acid Reflux \/ GERD","url":"gerd"},{"displayNavName":"Cervical Cancer \/ HPV Vaccine","url":"cervical_cancer"},{"displayNavName":"Eating Disorders","url":"eatingdisorders"},{"displayNavName":"Pharmacy \/ Pharmacist","url":"pharmacy"},{"displayNavName":"Regulatory Affairs","url":"regulatoryaffairs"},{"displayNavName":"Ovarian Cancer","url":"ovarian_cancer"},{"displayNavName":"Menopause","url":"menopause"},{"displayNavName":"Psoriasis","url":"psoriasis"},{"displayNavName":"Tuberculosis","url":"tuberculosis"},{"displayNavName":"Back Pain","url":"back-pain"},{"displayNavName":"Heart Disease","url":"heart-disease"},{"displayNavName":"Asbestos \/ Mesothelioma","url":"asbestos"},{"displayNavName":"Lymphology \/ Lymphedema","url":"lymphology"},{"displayNavName":"Veterans \/ Ex-Servicemen","url":"veterans"},{"displayNavName":"Medical Practice Management","url":"medical_practice"},{"displayNavName":"Melanoma \/ Skin Cancer","url":"melanoma"},{"displayNavName":"COPD","url":"copd"},{"displayNavName":"Palliative Care \/ Hospice Care","url":"palliative_care"},{"displayNavName":"Vascular","url":"vascular"},{"displayNavName":"Fibromyalgia","url":"fibromyalgia"},{"displayNavName":"Pancreatic Cancer","url":"pancreatic-cancer"},{"displayNavName":"Preventive Medicine","url":"preventive-medicine"},{"displayNavName":"Swine Flu","url":"swine-flu"},{"displayNavName":"Restless Legs Syndrome","url":"restless-legs"},{"displayNavName":"Food Intolerance","url":"food-intolerance"},{"displayNavName":"Personal Monitoring","url":"personal-monitoring"},{"displayNavName":"Surgery","url":"surgery"},{"displayNavName":"Emergency Medicine","url":"emergency-medicine"},{"displayNavName":"Pulmonary System","url":"pulmonary-system"},{"displayNavName":"Medical Innovation","url":"medical-innovation"},{"displayNavName":"Ebola","url":"ebola"},{"displayNavName":"Ulcerative Colitis","url":"ulcerative-colitis"},{"displayNavName":"Constipation","url":"constipation"},{"displayNavName":"Arrhythmia","url":"arrhythmia"},{"displayNavName":"Osteoporosis","url":"osteoporosis"},{"displayNavName":"Diabetes Type 1","url":"diabetes-type-1"},{"displayNavName":"Diabetes Type 2","url":"diabetes-type-2"},{"displayNavName":"Dry Eye","url":"dry-eye"},{"displayNavName":"Endometriosis","url":"endometriosis"},{"displayNavName":"Psoriatic Arthritis","url":"psoriatic-arthritis"},{"displayNavName":"Hypothyroid","url":"hypothyroid"},{"displayNavName":"Shingles","url":"shingles"},{"displayNavName":"Premature Ejaculation","url":"premature-ejaculation"},{"displayNavName":"Asthma","url":"asthma"},{"displayNavName":"VTE","url":"vte"},{"displayNavName":"Seasonal Allergy","url":"seasonal-allergy"},{"displayNavName":"Food Allergy","url":"food-allergy"},{"displayNavName":"OAB","url":"oab"},{"displayNavName":"Urinary Tract Infection","url":"urinary-tract-infection"},{"displayNavName":"Leukemia","url":"leukemia"},{"displayNavName":"Osteoarthritis","url":"osteoarthritis"},{"displayNavName":"Rheumatoid Arthritis","url":"rheumatoid-arthritis"},{"displayNavName":"Birth Control","url":"birth-control-contraception"},{"displayNavName":"Head and Neck Cancer","url":"head-and-neck-cancer"},{"displayNavName":"Atopic Dermatitis","url":"atopic-dermatitis-eczema"},{"displayNavName":"Bites and Stings","url":"bites-stings"}];
			var glob_testServer = 0;
			var resetpw = 0;
			var glob_newSkin = 1;
			var glob_menu_prefix = 'New Header';
			var glob_deviceInfo = 'Desktop';
			var glob_newRegistration = 1;
			var glob_triggerSurvey = 0;
			var glob_pageType = 'article';
			var glob_siteRevision = 7721;
			var showNewsletterPopup = 1;
			var showFocusGroupPopup = 0;
			</script>



							<script type="text/javascript" src="https://cdn-prod.medicalnewstoday.com/structure/javascript/out/mnt_default.js?v=190904" defer></script>
				
		<script src="https://healthline-com.videoplayerhub.com/galleryloader.js" defer></script>

	




<script type="text/javascript">

	fireOrSaveJsFunctions(1,function(){

		var tempAacctTid =setInterval(function() {

			if(typeof _qevents !== "undefined"){
				//wait until _qevents had been set
				_qevents.push( { qacct:"p-v03RmX3GES6RT"} );
				clearInterval(tempAacctTid);
			}

		}, 500);

	});

</script>
<noscript>
	<div style="display: none;">
		<img src="https://pixel.quantserve.com/pixel/p-test123.gif" height="1" width="1" alt="Quantcast"/>
	</div>
</noscript>


<script src="https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/oct.js" type="text/javascript"></script>
<script type="text/javascript">

	fireOrSaveJsFunctions(1,function(){
		twttr.conversion.trackPid('l4bfr');
	});

</script>
<noscript>
	<img height="1" width="1" style="display:none;" alt="" src="https://analytics.twitter.com/i/adsct?txn_id=l4bfr&p_id=Twitter" />
</noscript>



<div id="fb-root"></div>
<script>


	fireOrSaveJsFunctions(1,function(){

		(function(d, s, id) {
  var js, fjs = d.getElementsByTagName(s)[0];
  if (d.getElementById(id)) return;
  js = d.createElement(s); js.id = id;
  js.src = "//connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.3&appId=147184211975697";
  fjs.parentNode.insertBefore(js, fjs);
		}(document, 'script', 'facebook-jssdk'));

	});


</script>






<script>
	glob_categoryID="9";glob_categoryName="Breast Cancer category";glob_bindingK1="breastcancer";</script>



<div id="amzn-assoc-ad-c3555b57-ee3e-4ba5-b6f4-ec40911af7e4"></div>
<script>

	fireOrSaveJsFunctions(1,function(){loadScript(
		"//z-na.amazon-adsystem.com/widgets/onejs?MarketPlace=US&adInstanceId=c3555b57-ee3e-4ba5-b6f4-ec40911af7e4",
		{},
		function(){}

	)});

</script>


	<script>
		// 1. create object of script
		var deferCSS = document.createElement('script');
		deferCSS.src = 'https://hello.myfonts.net/count/333229';
		deferCSS.type = 'text/javascript';
		deferCSS.defer = true;

		// 2. declaire position of </body>
		var deferCSS_place = document.getElementsByTagName('body')[0];

		// 3. insert object before </body>
		deferCSS_place.appendChild(deferCSS);
	</script>




<!-- Begin medicalnewstoday.com BlueKai Tag --> 
<script type="text/javascript"> 
window.bk_async = function() { 
	bk_addPageCtx('categoryMain', 'breast_cancer');
	bk_addPageCtx('categorySub', '');
	bk_addPageCtx('dimension28', 'breastcancer');
	bk_addPageCtx('dimension29', 'cancer');
	BKTAG.doTag(76945, 10);
}; 
(function() { 
	var scripts = document.getElementsByTagName('script')[0]; 
	var s = document.createElement('script'); 
	s.async = true; 
	s.src = "https://tags.bkrtx.com/js/bk-coretag.js"; 
	scripts.parentNode.insertBefore(s, scripts); 
}()); 
</script> 
<!-- End BlueKai Tag --> 




<script type="text/javascript" >
				var articleID="325689";
				var articleType = "drugs";
				var emailID = "325689";
				var articleURL = "/articles/325689.php";
				var threadID = "0";
				var opinionsOutput = 0;
				var showAdsOnArticle = 1;
				var isSponsored = 0;
				</script>
    <script type="text/javascript">
    
		for(var contentBlocksDoms=document.querySelectorAll(".infobox_large.article-tcblocks > li"),i=0;i<contentBlocksDoms.length;i++){var _this=contentBlocksDoms[i],mobileHeadline=_this.querySelector("a  > div.headline.mobile"),excerpt=_this.querySelector("a > div > .excerpt"),desktopHeadlineHtmlStr=mobileHeadline.outerHTML;desktopHeadlineHtmlStr=desktopHeadlineHtmlStr.replace(/(class=\".*?)\s*mobile\s*(.*?\")/g,"$1$2"),null===_this.querySelector("a > div > .headline")&&excerpt.insertAdjacentHTML("beforebegin",desktopHeadlineHtmlStr),_this.getElementsByTagName("a")[0].removeChild(mobileHeadline)}

		//Remove  class hide in tabbed content to show on desktop/ tablet
		if(document.getElementsByClassName("collapsed__tabs")[0]){
			document.getElementsByClassName("collapsed__tabs")[0].classList.remove('hide');	
		}

    </script>



	<script type="text/javascript">

		var articleTOC = document.getElementsByClassName("article_toc")[0];

		if(document.body.contains(articleTOC)){
			// if the page contains article TOC, we do the trick
			var articleTOCpreviousElement = articleTOC.previousElementSibling;

			if(articleTOCpreviousElement){
				if((articleTOCpreviousElement.className.indexOf("photobox_header") !==-1&&articleTOCpreviousElement.querySelector("em") != null)||(articleTOCpreviousElement.className.indexOf("photobox_left") !==-1&&articleTOCpreviousElement.querySelector("em") != null)||(articleTOCpreviousElement.className.indexOf("photobox_right") !==-1&&articleTOCpreviousElement.querySelector("em") != null)){
					articleTOC.classList.add("article_collapsed--top");
				}
			}

		}

	</script>



	<input type="hidden" id="newsid" name="newsid" value="325689">
	<input type="hidden" id="categoryid" name="categoryid" value="9">
	<input type="hidden" id="glob" name="glob" value="0">
	<input type="hidden" id="ratingHCP" name="ratingHCP" value="0">
	<input type="hidden" id="ratingPublic" name="ratingPublic" value="0">
	<input type="hidden" id="alreadyRated" name="alreadyRated" value="0">
	<input type="hidden" id="kcarticle" name="kcarticle" value="0">
	<input type="hidden" id="bottomRatingsBoxReadOnly" name="bottomRatingsBoxReadOnly" value="true">
		
	
				<script type="text/javascript" src="https://cdn-prod.medicalnewstoday.com/structure/javascript/out/mnt_article_7721.js" defer></script>
		

		




<script type="text/javascript">
var mntDataLayer = "";
//Fire in adblock.js cause that's the last event in the page 
function setMNTDataLayer(e) {
	mntDataLayer = {"article_meta":{"publisher":"Medical News Today","headline":"Talzenna (talazoparib)","description":"Talzenna (talazoparib) is a prescription drug that's used to treat certain types of breast cancer. It\u2019s prescribed for breast cancer that\u2019s HER2-negative, locally advanced or metastatic, and BRCA-positive. Talzenna comes as oral capsules that are taken once daily. Learn about side effects, warnings, dosage, and more.","url":"\/articles\/325689.php","CanonicalURL":"https:\/\/www.medicalnewstoday.com\/articles\/325689.php","datePublished":"2019-08-15","dateUpdated":"","dateReviewed":"2019-06-23","author":"Lindsay Slowiczek, PharmD","coAuthor":"","reviewer":"Zara Risoldi Cochrane, PharmD, MS, FASCP","ratingHCP":0,"ratingPublic":0,"commentCount":0,"shareCountFacebook":0,"shareCountGooglePlus":0,"shareCountLinkedIn":0,"shareCountPinterest":0,"ampURL":"","ampVersion":"N"},"reader":{"loggedIn":"no"},"targeting":{"categoryMain":"breast_cancer","categorySub":[""],"articleKeywords":"","articleID":"325689","articleType":"drugs","micrositeID":"talzennacdi","articleVersion":"v2","articleAge":"month"},"customDimensions":{"siteVersion":"desktop","webServer":-1,"iosAppTraffic":-1,"viewportWidth":0,"viewportHeight":0,"hidpi":0,"adblockStatus":0}}
	mntDataLayer["article_meta"]["shareCountFacebook"] 	 = facebookCount;
	mntDataLayer["article_meta"]["shareCountGooglePlus"] = googlePlusCount;
	mntDataLayer["article_meta"]["shareCountLinkedIn"] 	 = linkedinCount;
	mntDataLayer["article_meta"]["shareCountPinterest"]	 = pinterestCount;
	mntDataLayer["article_meta"]["url"]	 				 = window.location.href;
	mntDataLayer["customDimensions"]["adblockStatus"] 	 = adBlockValue;
 	mntDataLayer["customDimensions"]["viewportWidth"] = Math.max(document.documentElement.clientWidth, window.innerWidth || 0);
 	mntDataLayer["customDimensions"]["viewportHeight"] = Math.max(document.documentElement.clientHeight, window.innerHeight || 0);
 	mntDataLayer["customDimensions"]["hidpi"] = (window.devicePixelRatio >= 1.5) ? "HiDPI" : "1X";
}
</script>

					
			
</div> </body>
</html>
